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Coronary artery disease (CAD) is the most common cause of mortality. Invasive coronary 
angiography remains the gold standard for the diagnosis of patients with stable CAD and acute 
coronary syndromes (ACS). However, the accurate diagnosis of CAD is complex and may involve 
a number of different investigations, including non-invasive techniques, primarily based on patient 
symptoms. The aim of this thesis was to investigate the prediction of CAD from coronary calcium 
scoring using multi-detector computed tomography (MDCT) against exercise treadmill testing 
(ETT [n=360]), myocardial perfusion imaging using magnetic resonance imaging (CMR [n=120]), 
and myocardial ischaemia assessed using Dobutamine stress echocardiography (DSE [n=35]) in a 
retrospective cohort of patients with typical chest pain. All 515 patients underwent conventional 
coronary angiography within 1-month of their non-invasive investigations. The results of this 
thesis demonstrated that MDCT is more accurate than ETT in identifying significant CAD, 
whereas a negative ETT was accurate in excluding CAD, as such the two investigations are 
complementary. Compared to CMR, MDCT was more accurate in detecting significant CAD. 
However, the burden of perfusion defects during stress was associated with a progressive increase 
in CAC in patients with non-obstructive CAD only. Finally, DSE was abnormal in patients with 
non-significant coronary stenosis but with high CAC and a positive ETT, which may suggest 
microvascular disease. In addition, resting wall motion abnormalities on echocardiography was 
associated with coronary calcification by MDCT. Non-invasive techniques for the assessment, 
diagnosis and treatment of CAD remains an integral component for the investigation of chest pain. 
Future research is required to investigate the relative importance of non-invasive assessments of 
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GENERAL INTRODUCTION AND LITERATURE REVIEW 
 
Coronary artery disease (CAD) is the commonest cardiovascular disease and the leading single 
cause of morbidity and mortality. Each year around 70.000 individuals die from CAD in the UK 
(British Heart Foundation, 2016). Angina is a symptom associated with obstruction or spasm of 
the coronary arteries. It is characterised by chest pain or discomfort, squeezing, burning or fullness, 
arm, neck, jaw, shoulder or back pain accompanying chest pain. Sometimes it is presented by 
nausea, breathlessness, dizziness, sweating and fatigue. There are many types of angina, including 
stable angina, which is produced by exertion and relieved by rest or medications, and unstable 
angina, which can occur at rest and has a more adverse prognosis than stable angina. The last one 
is variant angina or Prinzmetal's angina, which is microvascular angina. It may occur at rest due 
to either microvascular disease or due to vasospasm, and it is improved by medications (Sani et 
al., 2015). 
One in seven women and one in five men die from CAD (British Cardiovascular Intervention 
Society, 2020). CAD is the most common cause of death in people aged more than 35 years, and 
it is the most common cause of death in the European Union (Townsend et al., 2016).  In Europe, 
more than 335,000 men and more than 297,000 women die yearly due to CAD (British Heart 
Foundation, 2017). The conventional gold standard for diagnosing CAD is based on coronary 






Pathophysiology of coronary artery disease  
 
CAD is characterized by atherosclerosis within the wall of coronary arteries, which is due to 
deposits of cholesterol (plaque) in the arteries. The atheromatous plaque grows progressively 
leading to narrowing of the arterial lumen, which may develop into angina.  
The non-modifiable risk factors for CAD include age, male gender, ethnicity and family history of 
CAD, which is associated with early development of CAD. Modifiable risk factors, such as high 
cholesterol, hypertension, diabetes mellitus (DM), smoking, obesity, and physical inactivity can 
be changed and can be controlled. (Rosamond et al., 2008). Importantly, these risk factors can 
accelerate low-grade inflammation of the inner lining (intima) of medium-sized arteries. 
Atherosclerosis progresses slowly leading to gradual thickening of the intima (figure 1). The 
plaque consists of inflammatory cells, cellular debris, smooth muscle cells, and different amounts 
of cholesterol and cholesterol ester. When plasma cholesterol increases, the arterial endothelial 
permeability changes, and this allows the LDL-C particles to move into the arterial wall, and the 
formation of intraluminal thrombus may occur.  
This thrombus may dissolve spontaneously or grow and progress to occlude a coronary artery and 
result in an acute coronary accident. All these stages depend on a number of factors, such as plaque 
composition, plaque volume, the degree of luminal narrowing, and the size of the cap tear 




Figure 1: Normal artery and narrowed artery due to plaque. (Permitted)  
 
 
According to the American College of Cardiology (ACC) and American Heart Association (AHA), 
coronary atherosclerosis is defined when there is calcification in the epicardial coronary arteries 
(O’Rourke et al., 2000). However, calcification is not only found in advanced lesions, but it may 
appear in small amounts in early stage lesions in people in their second and third decade of life 
(Wexler et al., 1996).  
Impaired arterial compliance may affect the ability of an artery to dilate, particularly during 




In females, low indexed arterial compliance is associated with high coronary artery calcification 
(Coutinho et al., 2017). The coronary arterial stiffness measurements are strongly associated with 
the presence of CAD and its progression (Hack-Lyoung Kim, 2016). A reduction in arterial 
compliance is due to changes in the arterial wall, and this may come before the symptoms of the 
arterial disease (Glasser et al., 1997). Cardiac risk factors such as hypertension, DM, age, and 
atherosclerosis attenuate arterial compliance. The early detection of vascular abnormalities such 
as a decrease in arterial compliance may lead to increased risk of clinical events (Glasser et al., 
1997). 
During vasospasm of as coronary artery, vasoconstrictors such as angiotensin II and endothelin 1 
are elevated compared to acetylcholine and nitric oxide (Yasue et al., 2008). Many studies have 
shown that nitric oxide deficiency is associated with coronary vasospasm (Kaneda et al., 2006). 
On the other hand, other studies reported that nitric oxide levels are not decreased during coronary 
vasospasm (Egashira et al., 1996). Moreover, enhanced phospholipase C activity and the increase 
in thioredoxin, C-reactive protein (CRP), and monocyte levels are associated with coronary 
vasospasm (Nakano et al., 2002). Anxiety, panic disorder, and type A personality also have been 
associated with coronary vasospasm (Stern and Luna, 2009). One other indicator of the presence 
of arterial disease is a reduction in arterial compliance (Glasser et al., 1996). Cardiovascular 








Syndrome X is a form of angina-like chest pain associated with ST depression on exercise; 
however, patients have normal coronary arteries when viewed using conventional coronary 
angiography.  
Physiological mechanism of syndrome X: 
 
The physiological mechanism(s) of syndrome X remain unclear and the optimum management of 
this patient population remains a clinical challenge (Crea and Lanza, 2004). These patients are 
diagnosed with other non-cardiac diagnoses, such as psychiatric and gastrointestinal disorders 
(Phan et al., 2009). There are some proposed causes such as endothelial dysfunction, estrogen 
deficiency, insulin resistance, and abnormal autonomic control (Kaski, 1999, Rosano et al., 1994, 
Roqué et al., 1998,  Bøtker et al., 1993). Other (Agrawal et al., 2014) proposed criteria of syndrome 
X include:  
1. Chest discomfort on exertion.  
2. ST-segment depression during the anginal symptoms. 
3. Normal coronary arteries at angiography. 
4. Inducible coronary artery spasm upon egonovine or acetylcholine provocation 
5. Absence of any systemic diseases associated with microvascular dysfunction. 
Myocardial bridging is when the epicardial coronary vessel enters into the myocardium, it is 
associated with microvascular endothelial dysfunction in those patients with non-obstructive 
CAD, and it is investigated by intravascular ultrasound.  
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Endothelial dysfunction is characterised by a decrease in epicardial coronary artery diameter >20% 
after intracoronary acetylcholine and microvascular dysfunction when the index of 
microcirculatory resistance ≥25 (Sara et al., 2020, Pargaonkar et al., 2019). Other syndrome X 
patients may present with features of the metabolic syndrome such as hyperlipidaemia and 
hypertension (Jadhav et al., 2006).  
Syndrome X in clinical studies: 
 
Many studies suggested that the main cause of syndrome X is coronary microvascular dysfunction 
and microvascular angina (Crea and Lanza, 2004). Patients with Syndrome X remain a clinical 
challenge in their management. The exact mechanism behind symptoms in Syndrome X patients 
remains disputable (Agrawal et al., 2014). In general, syndrome X is still not fully understood, and 
there are no clear guidelines for its treatment (Agrawal et al., 2014). Another important cause of 
chest pain is the constriction of the coronary artery smooth muscles (coronary artery vasospasm).  
Patients at intermediate risk of CAD might present with typical or atypical angina-like symptoms. 
For these patients, current guidelines recommend MDCT for the assessment of CAC score for 
optimum risk stratification (De Backer et al., 2003, Greenland et al., 2010). 
There is no difference between 0 CAC and >0 CAC patient with the cardiac risk factor of age, 
male gender and smoking. However, patients with DM and hypertension have significantly higher 
CAC. It has been shown that diabetic patients always have a CAC greater than zero (Shipman et 
al., 2015). In terms of lipid profile, there is an association between hyperlipidemia and the extended 
CAC in more than one coronary artery (Abd Alamir et al., 2018). In addition, there is a strong 
association between age and gender with the presence of CAC. (Pletcher et al., 2004b) 
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The process of coronary calcification due to hypertension is not just because of hypertension, but 
it might be multifactorial (Megnien et al., 1996). Patients with a CAC >0 and diastolic blood 
pressure <60 mmHg have a high risk of CAD events (Rahman et al., 2017). Extra high CAC 
patients have a high risk of developing hypertension (Aladin et al., 2018). In diabetic patients, the 
mortality rate is expected to be high in patients with high CAC (Agarwal et al., 2013). 
Asymptomatic diabetic patients with zero CAC have good 5 year prognosis; however, the 
mortality rate increases significantly after 5 years (Valenti et al., 2016). Zero CAC is associated 
with good prognosis in older smokers. However, the presence of CAC is associated with a high 
predictive mortality rate, even in the absence of other cardiac risk factors (Schulman-Marcus et 
al., 2014). People with a family history of CAD and CAC of zero have a high risk of CAD events 
(Cohen et al., 2014). 
The direct relationship between the extent of CAC and the functional status of the coronary 
circulation remains controversial (Henneman et al., 2008). Although CAC is perceived as a sub-
clinical form of atherosclerosis, severe forms exist in the asymptomatic general population, while 
zero CAC has been reported in patients with acute coronary syndrome (Henneman et al., 2008, 
Schuijf et al., 2009).  
Clinical investigations for CAD:  
There are invasive and non-invasive techniques to diagnose CAD in patients with angina like 
symptoms. Invasive coronary angiography continues to be the gold standard in the diagnosis of 




Although ETT is not recommended by NICE guideline but remains a practical investigation for 
excluding CAD as an explanation for exertional angina-like symptoms, and with a negative stress 
test often being used to rule out the need for coronary angiography (Desideri et al., 2005) or other 
non-invasive investigations. According to NICE guidelines, the current first line investigation for 
patients with typical / stable chest pain is CT angiography (Koo et al., 2011). The cardiac risk 
factors should be taken into account, including, age, gender, smoking history, diabetes, 
hypertension, dyslipidaemia and family history of premature CAD. NICE guidelines also 
recommend taking a resting 12-lead ECG as soon as possible in these patients. CT angiography 
should be used if the clinical assessment suggests typical and atypical angina, or 12-lead resting 
ECG demonstrates ST/T wave changes or Q waves. Patients should be offered other non-invasive 
functional imaging for myocardial ischaemia such as DSE or CMR if CT angiography has non-
diagnostic results. Conventional coronary angiography may be considered as a third-line when the 
results of non-invasive functional imaging are non-conclusive. In terms of medical treatment, 
according to NICE guidelines, clinicians should consider a short-acting nitrate for preventing and 
treating episodes of angina. For secondary prevention, aspirin 75 mg daily, angiotensin-converting 
enzyme (ACE) inhibitors, statin and treat hypertension. Offer either beta blockers or a calcium 
channel blocker as first-line treatment for stable angina. Beta-blocker or calcium channel blocker 
pharmacotherapy should be based on contraindications and the individual’s preference and 
comorbidities. Consider adding a third anti-anginal drug only when there is persistent chest pain 





For male patients with a normal resting electrocardiograph (ECG) who are able to exercise, the 
1997 ACC/AHA guidelines for exercise testing, as modified in 2002, recommend risk factor 
assessment and ETT, because of its simplicity, low cost and the widespread familiarity with its 
performance and interpretation, to determine whether the patient is at low, intermediate or high 
risk (Gibbons et al., 2002). 
 It is recognised that ETT is of less value in women due to a poorer accuracy of ECG changes as a 
result of more frequent resting ST-T-wave changes, lower ECG voltage and hormonal factors 
(Mieres et al., 2005). 
Cardiac magnetic resonance imaging (CMR) myocardial perfusion has high diagnostic accuracy 
for CAD, even superior to single-photon emission computed tomography (Greenwood et al., 
2012), however, it is known for its limitations.  
The diagnosis of CAD by the two techniques is based on different concepts; while CMR assesses 
myocardial perfusion as a consequence of coronary disease, MDCT analyses the arterial disease 
morphology and allows for quantification of coronary wall calcification. In addition, MDCT non-
invasive coronary angiography has shown higher accuracy than CMR in determining coronary 
stenosis (Schuijf et al., 2006). CAC score assessed by MDCT has also been shown to have high 
specificity in excluding obstructive CAD (Nieman et al., 2009b) 
Coronary calcification itself generally reflects atherosclerosis and its extent correlates with the 
overall plaque burden, in the form of luminal stenosis (Rennenberg et al., 2009). However, many 
symptomatic patients might present with coronary calcification in the absence of significant 
luminal stenosis, suggesting that arterial wall hardening could be associated with ischaemia and 
compromised myocardial blood supply as a cause of symptoms.  
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Dobutamine stress echocardiography is an accurate non-invasive technique for detecting coronary 
artery disease (Senior et al., 2005). Currently, the clinical idea of the technique is based solely on 
the detection of ischaemia-induced wall motion abnormalities.  
Multi-detector Computed Tomography (MDCT) 
 
Non-invasive imaging techniques may enable early detection of CAD before significant luminal 
stenosis. Cardiac CT for CAC is a non-invasive technique for obtaining information about the 
location and extent of calcified plaque in the coronary arteries that cause narrowing of the coronary 
arteries or even block blood flow to the heart. CAC is a marker of CAD (American College of 
Radiology (ACR) and the Radiological Society of North America (RSNA), 2020). In 1994 a two-
slice scanner was introduced, followed by a four-slice scanner in 1999. Then 16-slice, 32-slice, 
and 40-slice scanners have been introduced, with the latest being a 64-slice scanner in 2004 (Mittal 
et al., 2006, Flohr et al., 2003). In the future, MDCT coronary angiography is expected to become 
an alternative to invasive angiography for the diagnosis of significant coronary artery occlusions. 
Invasive coronary angiography assesses just the arterial lumen, detecting the location and severity 
of lumen narrowing, but is unable to give information about the arterial wall.  
MDCT for CAC is a non-invasive way of evaluating the coronary arteries, after the technique no 
radiation remains in a patient's body. The CAC provides information about whether CAD is present 
even if the patient is asymptomatic or is likely to develop CAD in the next few years. The cardiac 
CT can suggest the presence of CAD even when the coronary arteries are less than 50 percent 
narrowed (Mittal et al., 2006, Agatston et al., 1990, Callister et al., 1998, Ferencik et al., 2003, 
Hong et al., 2002, Matthew Budoff and Jerold Shinbane, 2016, Alan Boyar, 2020). 
24 
 
CAC is indicated in the screening of young people with risk factors of CAD such as family history 
of CAD, diabetes, hypercholesterolemia, hypertension, obesity, and smoking (Saad et al., 2018). 
Also, CAC should be checked annually in all asymptomatic patients with high CAC. In dilated 
cardiomyopathy, CAC can be used to determine the presence and extent of CAD. It may be helpful 
in assessing whether the cardiomyopathy is due to ischaemic heart disease.  
A very low CAC would indicate that the cardiomyopathy is of unknown origin, so invasive 
coronary angiography would be unnecessary. When CAC is 0, the probability of finding coronary 
artery stenosis is about 0% for women and 0.7% for men (American College of Radiology (ACR) 
and the Radiological Society of North America (RSNA), 2020, Matthew Budoff and Jerold 
Shinbane, 2016). MDCT is contraindicated in patients with arrhythmias, pregnant women, 
iodinated contrast material allergy, renal failure, and hyperthyroidisms (American College of 
Radiology (ACR) and the Radiological Society of North America (RSNA), 2020, Alan Boyar, 
2020).  
There are several methods of measuring CAC. The Agatston scoring scale is rule-based and uses 
the weighted sum of all lesions with a density above 130 Hounsfield Units (HU) and multiplying 
the area of calcium by a factor related to maximum plaques attenuation (density factor).  
Partial volume effects lead to higher peak values only for small lesions (Agatston et al., 1990). The 
volume method of (Callister et al., 1998) resolves the issue of slice thickness and spacing by 
computing a volume above threshold. The calcium mass score consists of an integration of the 
signal for pixels above a given threshold. This score however, has not been clinically validated 
(Ferencik et al., 2003, Hong et al., 2002). Rumberger et al (2003) data showed that the Agatston, 
Volume, and Mass scores could provide similar but not exactly the same characterization. CAC 
levels and its relations to the presence of plaques and their severity are shown in table 1.  
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The Coronary Calcium Score (CAC) Interpretations is as follows: 
Table 1: Coronary Calcium Score Interpretations (American College of Radiology (ACR) and 
the Radiological Society of North America (RSNA), 2020) 
Calcium Score  Presence of Plaque 
0 No evidence of plaque  
1-10 Minimal evidence of plaque 
11-100 Mild evidence of plaque 
101-400 Moderate evidence of plaque 
Over 400 Extensive evidence of plaque 
 
Table 2 shows the impact of CAC level on the presences of CAD, and cardiovascular risk, and the 










Table 2: Calcium Score Guidelines (Alan Boyar, 2020) 






No identifiable plaque 
burden 
Very low (generally <5% 
likelihood) 
Very low CV risk 
Reassure patient while 
discussing general public 
guidelines for primary CV 
prevention. 
0-10 
Minimal identifiable plaque 
burden 
Very unlikely (generally 
<10% likelihood) 
Low CV risk 
Discuss general public 
health guidelines for 
primary CV prevention. 
11-100 Definite (at least mild) 
Mild or minimal coronary 
stenoses likely 
Moderate CV risk 
Counsel patient on risk 
factor modification, with 
strict adherence to NCEP 
ATP II primary prevention 
cholesterol guidelines. 
101-400* 
Definite (at least moderate 
atherosclerotic plaque 
burden) 
Nonobstructive CAD highly 
likely, although obstructive 
disease possible 
Moderate to high CV risk 
Institute risk factor 
modification and secondary 
prevention NCEP ATP II 
guidelines. Consider stress 
testing for further risk 
stratification. 
>400* (*Greater clinical 
significance if calcium score 
is >75th percentile for age 
and sex.) 
Extensive 
High likelihood (>90%) of at 
least one "significant" 
coronary stenosis 
High CV risk 
Very aggressive risk factor 
modification and stress 





People with higher CAC have greater plaque burden and high risk for myocardial infarction (MI) 
regardless of their symptoms. The presence of MI is well described with retrospective 64-slice CT 
(Francone et al., 2007). For asymptomatic people, a CAC of 0 indicates the absence of CAD, 
whereas CAC over 400 is associated with high cardiac event rates (Matthew Budoff and Jerold 
Shinbane, 2016, Alan Boyar, 2020). The disadvantage of the MDCT is that it exposes the patient 
to radiation. The dose is similar to 50-180 chest x-rays and about similar to that received during a 
diagnostic cardiac catheterisation procedure. The effective radiation dose for cardiac CT for CAC 
is around 3 Sub-millisievert (mSv) (depending on dose modulation strategies), whereas effective 
radiation dose for cardiac catheterisation average 8 to 10 mSv. From 2007 to 2017, the MDCT 
radiation dose decreased by around 80%, the median effective dose decreased from 12.4 mSv to 
2.7 mSv (Stocker et al., 2018). The combination of adaptive iterative reconstruction algorithms, 
tube current modulation, tube voltage reduction, heart rate reduction, prospective 
electrocardiogram-gating and high-pitch helical acquisition are responsible for reduction in the 
radiation doses during the coronary computed tomography angiography in the diagnosis of CAD 
(Richards and Obaid, 2019). 
Radiation exposure of cardiac MDCT is approximately the same as a CT scan of the chest or 
abdomen; however, it is slightly higher than invasive coronary angiography. The approximate 
radiation dose exposure during 64-slice CT was 13 mSv and 18 mSv for men and women 
respectively (Raff et al., 2005). The increase in spatial and temporal resolution with 64-slice CT 
is associated with an increased radiation dose (Pitcher et al., 2007). The radiation dose significantly 
decreases with increasing heart rates (Stolzmann et al., 2008). The radiation dose exposure during 
16-slice CT is reduced by 30%-50% (according to heart rate) with ECG pulsing (Flohr et al., 2003).  
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MDCT is a reliable test to detect coronary artery stenosis in patients with sinus rhythm, presenting 
with atypical chest pain, stable or unstable angina (Rubinshtein et al., 2007, Mollet et al., 2005, 
Cademartiri et al., 2006).  
Emergency department MDCT has a high positive predictive value for ACS diagnosis. Coronary 
32-slice CT excludes coronary stenosis of 50% in patients with high CAC and advanced CAD 
(Cordeiro et al., 2006). Normal cardiac MDCT has an excellent prognosis (Gaemperli et al., 2008). 
Schlosser et al (Schlosser et al., 2007) reported that MDCT may overestimate the severity of 
coronary stenosis. MDCT is able to evaluate the nature and severity of arterial wall disease in 
patients presented with cardiac chest pain (Pitcher et al., 2007).  
Meta-analysis data showed that MDCT has shortcomings, which are difficult to overcome in daily 
practice (Hamon et al., 2006). Niemann et al (2001) found that only 76% of coronary segments 
could be evaluated by MDCT. However, most published studies illustrate that CAC predicts CAD 
events regardless of risk factors. The ability of the CAC to estimate total plaque burden is the most 
important predictor for future myocardial events (Hasdai et al., 1997).  A negative CAC (0 calcium 
score) is associated with a 0.1% per year risk for a hard coronary event (Secci et al., 1997, 
O’Rourke et al., 2000).  
Greenland et al (2004) data showed that patients with CAC >300 are considered as high risk. Arad 
et al (2000) illustrated that a CAC >160 was highly predictive of nonfatal MI and death due to 
CAD. CAC predicted events independently of age, gender, and other cardiovascular risk factors. 
The lack of calcium does not completely rule out CAD (Wong et al., 2000). A four-year follow-
up study (Arad et al., 2005) showed a higher incidence of adverse cardiovascular events in patients 
aged between 50 and 70 years old with no symptoms and CAC of ≥100.  
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Cooper Clinic Study (LaMonte et al., 2005) investigated more than ten thousand adults, aged 
between 22 and 96 years unknown for CAD and the study demonstrated a strong association 
between CAC and incident coronary heart disease events.  
A meta-analysis showed the risk of CAD events increased 2.1-fold for CAC from 1 to 100 and 10-
fold for CAC >400 (Pletcher et al., 2004a). People with very high CAC without cardiac symptoms 
have a 25% higher risk annually of having an MI or dying due to cardiovascular causes (Wayhs et 
al., 2002).  
The presence and extent of CAC are greater in young patients with acute MI (Pohle et al., 2003) 
and MDCT angiography provides promise to reduce the number of invasive angiography 
investigations in symptomatic patients with suspected CAD. However, calcium scoring alone was 
less appropriate as a filter before angiography (Haberl et al., 2005). Elevation of CAC ≥1000 is 
associated with increasing age and with a likelihood of coronary artery occlusion (Almeda et al., 
2004). The Multi-Ethnic Study of Atherosclerosis (MESA) (McClelland et al., 2006) examined 
the spread of CAC based on age, gender, and ethnicity in clinical cardiovascular disease and treated 
diabetes. The study showed that men had higher calcium levels than women. In addition, CAC 
increases steadily with the age. Moreover, there were significant differences in CAC by race.  
In diabetic patients, any increase in CAC was associated with an increase in mortality when 
compared with non-diabetic patients (Raggi et al., 2004).  
There is no evidence that a high CAC would be attenuated following cessation of smoking or with 
effective blood pressure control and diabetes management (Pearson et al., 2002). CAC is superior 
to most of the cardiac risk factors such as gender, DM, hypercholesterolemia, hypertension, age 
and family history, in identifying significant CAD (Nicoll et al., 2016).  
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MDCT in clinical practice 
 
A large meta-analysis study comparing MDCT with ETT showed high sensitivities, specificities, 
and accuracy for the ETT in the range of 68%, 77%, and 73%, respectively; 89%, 80%, and 89% 
for myocardial perfusion; and 85%, 84%, and 87% for stress echocardiography compared with 
91%, 49%, and 70% for CT (O’Rourke et al., 2000).  
Other studies (Dennis et al., 1995, Fleischmann et al., 1998, Detrano et al., 1989) demonstrated 
lower and variable sensitivity and specificities of 84% to 44% for treadmill testing, 85% to 77% 
for stress echocardiography, and 87% to 63% for myocardial scintigraphy. Cardiac CT is more 
sensitive than ETT for the identification of patients with occluded CAD (Shavelle et al., 2000). 
CAC for occluded CAD is superior to ETT in asymptomatic high-risk patients (Geluk et al., 2007).   
Berman et al (2004) studied 1195 patients who underwent cardiac CT for CAC measurement and 
CMR single photon emission assessment. The study showed that CAC was frequently present in 
the absence of abnormalities in CMR. Other reports have supported this study (Brindis et al., 
2005). Ischaemic CMR is associated with a likelihood of atherosclerosis by CAC of >100 (Berman 
et al., 2004). A meta-analysis comparing MDCT to CMR showed higher diagnostic accuracy for 
MDCT than CMR (Schuijf et al., 2006). The sensitivity of cardiac CT was slightly higher than 
stress echocardiography, whereas the specificity was lower (Myers et al., 2002). The CAC was 
significantly lower in syndrome X patients than in CAD patients. CAC could differentiate between 
syndrome X and CAD in patients with chronic stable angina (Chen et al., 2001).  
Coronary artery wall calcification is a sensitive marker for the presence of atherosclerosis 
(Rumberger et al., 1995). 30% of the elderly male and 15% of the elderly female, without cardiac 
risk factors, had extensive coronary calcification (Oei et al., 2004).  
31 
 
The sensitivity of detecting CAD declines and the specificity increases with increasing CAC 
(Agatston et al., 1990, Budoff et al., 1996). Asymptomatic individuals with CAC >400 but have 
no cardiac risk factors may have a poorer prognosis than those who have zero CAC but have three 
or more cardiac risk factors (Nasir et al., 2012). In the future, CAC with other non-invasive cardiac 
investigation will play a very important role in daily clinical practice in the diagnosis of CAD 
(Piers et al., 2008). Recently, there is no medical treatment to stop the progress of coronary 
calcification or reduce the CAC (Liu et al., 2015). 
Exercise Treadmill Test (ETT) 
 
Exercise testing is the most widely used and relatively inexpensive method for the evaluation of 
suspected CAD and its severity (Kligfield and Okin, 1994, Detry et al., 1970).  
ST depression during ischaemia is due to spatial and non-spatial factors. The spatial factor is the 
myocardial ischaemic area, and the non-spatial factor is the physiological severity of ischaemia of 
the myocardium. The non-spatial factor becomes greater during exercise and it is responsible for 
the ST changes during the exercise test. Another non-spatial factor that may affect ST-segment 
depression during exercise is changing intra-ventricular conductance (Wilson et al., 1991, Holland 
and Arnsdorf, 1977). ST depression during exercise-induced ischaemia is not only due to the 
presence of coronary occlusion but also due to the increase in excess myocardial oxygen demand 
(Detry et al., 1970, Mirvis et al., 1986).  
Heart rate normally increases during exercise. The first increase in heart rate early in exercise is 
due to a central withdrawal of parasympathetic inhibition and an increase in sympathetic tone. 
Then there is a further increase in central nervous system sympathetic stimulation and increase in 
levels of circulating catecholamines (Lauer, 2004, Lauer, 2001).  
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Heart rate decrease during the first 30 seconds to 1 minute after exercise due to parasympathetic 
reactivation (Imai et al., 1994). ETT is indicated as a diagnostic test in suspected coronary artery 
disease patients, chest pain assessment, high-risk patients to identifying documented CAD, 
evaluate patients after CABG or angioplasty, and assessment of arrhythmia (Hill and Timmis, 
2002).  
ETT is contraindicated in:  
1-Acute MI (4 to 6 days). 
2-Unstable angina at rest within 48 hours. 
3-Recent aortic surgery. 
4-Arrhythmia.  
5-Acute myocarditis or pericarditis.  
6-SBP >220 mm Hg or diastolic >120 mm Hg.  
7-Severe aortic stenosis.  
8-Uncontrolled heart failure.  
9-Hypertrophic obstructive cardiomyopathy (HOCM).  
10-Dissecting aneurysm (Hill and Timmis, 2002). 
The ACC and the AHA performed a meta-analysis of the diagnostic accuracy of ETT for patients 
who underwent conventional coronary angiography and ETT. The sensitivity and the specificity 
were 68%, and 77%, respectively.  
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When the meta-analysis excluded the studies of patients with previous MI, the sensitivity and the 
specificity were 67%, 72%, respectively, for diagnosing CAD (Gibbons et al., 2002). The ADORE 
trial (Babapulle et al., 2007) divided ETT results to positive, indeterminate, and negative. They 
found that after PCI there is no significant difference in clinical events between patients with 
positive and negative ETT. This result supports the ACC/AHA guidelines that ETT should not be 
used routinely after PCI.   
Silent ischaemia during ETT is associated with an increased risk of stroke and cardiovascular 
disease in men with cardiac risk factors, such as hyperlipidaemia, hypertension, and smoking (Kurl 
et al., 2003).  In patients following an uncomplicated MI who had a negative ETT before discharge, 
have less cardiac events at one year follow up (Desideri et al., 2005). Curzen et al (1996) showed 
that a negative ETT in older women with cardiac risk factors have a very low predictive value. In 
patients with cardiac risk factors, ETT is a reliable and important investigation to detect CAD.  
In diabetic patients, a positive ETT is better than a positive thallium scan for detecting CAD in 
asymptomatic patients (Koistinen et al., 1990). Chest pain during ETT is strongly associated with 
nonfatal cardiac hospitalisations (Ho et al., 2007). Young women with the absence of chest pain 
during ETT are associated with a high negative predicted value (Curzen et al., 1996). During ETT, 
hypertensive patients with left ventricular hypertrophy may be associated with myocardial 
ischaemia in the absence of CAD (Manolis et al., 1997). Patients presenting with chest pain, 
hypertension, and insignificant ECG changes, had a higher risk of CAD (Conti et al., 2000).    
Exaggerated increases of systolic blood pressure (SBP) by >20 mmHg during ETT were associated 
with cardiovascular mortality, and risk of acute MI and stroke (Huang et al., 2008). SBP may 
increase during ETT in women with hyperlipidaemia (Kolovou et al., 2007).  
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Hypertensive patients with positive ETT had higher minimum coronary resistance and lower 
arterial compliance (Kozàkovà et al., 2003). Normotensive men with normal resting ECG and 
strong positive ETT are more likely to have CAD. The same study reported that hypertensive 
women with ischaemic resting ECG are more likely to have a false-positive ETT (Faisal et al., 
2007). ST segment depression on a resting ECG does not impair the detection of ischaemia by 
ETT but may be associated with a false-positive ETT (Kalaria and Dwyer, 1998).  
ST depression ≥2 mm during ETT is a predictor of reversible ischaemia, whereas ST depression 1 
mm during ETT was not a predictor of ischaemia (Yap et al., 2005). Prolonged ST-segment 
depression of more than five min in recovery does not relate to the severity of CAD (Desai et al., 
2003). However, there is a strong association between ST-segment depression during ETT and the 
magnitude of ischaemia (Hauser et al., 2004).  
Other ECG changes during exercise 
 
In 1986, Ahnve et al (1986) showed the prolonged QRS duration during exercise could be a marker 
of myocardial ischaemia. The QRS score provides complementary diagnostic information to ST-
segment depression during ETT (Koide et al., 2001). The differences in QRS duration from rest to 
exercise may work as a marker of myocardium ischaemia (Kligfield and Lauer, 2006, Koide et al., 
2001). Another study (Michaelides et al., 1995) showed that the QRS score was directly related to 
the number of occluded coronary arteries and to exercise-induced reversible myocardial perfusion 
defects. During ETT, transient abnormal Q waves are rare, as Q waves indicate an old MI 
(Alameddine and Zafari, 2004). In asymptomatic CAD patients, ETT is an acceptable technique 
in clinical follow-up (Guerreiro et al., 2017).  
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Increases in the duration of the P-wave together with ST depression during ETT is associated with 
high sensitivity in identifying three vessels CAD (Kuch, 2017). In men, ST depression during 
exercise with low cardiorespiratory fitness is associated with a high risk of sudden cardiac death 
(Hagnäs et al., 2017). MDCT is more accurate than ETT in the diagnosis and assessment of CAD 
(Yin et al., 2016). 
Cardiac Magnetic Resonance Imaging (CMR) 
 
Cardiac magnetic resonance imaging myocardial perfusion has high diagnostic accuracy for CAD, 
even superior to single-photon emission computed tomography (Greenwood et al., 2012); 
however, it is known for its limitations. CAC score assessed by MDCT has also been shown to 
have high specificity in excluding obstructive CAD (Nieman et al., 2009b). The diagnosis of CAD 
by the two techniques is based on different concepts; while CMR assesses myocardial perfusion 
as a consequence of coronary disease, MDCT analyses the arterial disease morphology and allows 
for quantification of coronary wall calcification. In addition, MDCT non-invasive coronary 
angiography has shown higher accuracy than CMR in determining coronary stenosis (Schuijf et 
al., 2006).  
Coronary calcification itself generally reflects atherosclerosis and its extent correlates with the 
overall plaque burden, in the form of luminal stenosis (Rennenberg et al., 2009). However, many 
symptomatic patients might present with coronary calcification in the absence of significant 
luminal stenosis, suggesting that arterial wall hardening could be associated with ischaemia and 
compromised myocardial blood supply as a cause of symptoms. 
Jaarsma et al (2012) meta-analysis showed that stress CMR has better diagnostic accuracy than 
DSE and MDCT.  
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CMR has more advantages than MDCT in the diagnosis and assessment of CAD, as CMR is not 
affected by the CAC which limit the benefits of MDCT in patients with advanced atheroma.  
(Kim et al., 2001) showed that CMR has very high sensitivity in identifying obstructed CAD, 
however, the specificity is low. In addition, meta-analysis illustrated that the overall sensitivity 
and specificity of CMR in detecting significant CAD were 87% and 70%, respectively (Schuetz et 
al., 2010). 
Dobutamine Stress Echocardiography (DSE) 
 
DSE is an accurate non-invasive technique for detecting coronary artery disease and has been 
shown sensitive even in demonstrating evidence for subendocardial ischaemia before transmural 
disturbances appear. DSE is more accurate than ETT in the diagnosis of CAD (Mahenthiran et al., 
2005). In the setting of a normal ECG and resting echocardiogram, DSE is an effective and safe 
investigation in the detection of early stages of CAD (Bedetti et al., 2005). DSE has more 
advantages than the other non-invasive investigations and recommended in the assessment of 
patients referred to invasive coronary angiography (Scherhag et al., 2005). 
In routine clinical practice, DSE has higher sensitivity and lower specificity in detection CAD 
(Geleijnse et al., 2009). In symptomatic outpatients, DSE is superior to ETT and should be 
performed in all symptomatic patients to clarify the cause (Leischik et al., 2007). DSE has average 
results for the diagnosis of CAD, with high sensitivity and specificity, but these results are not too 
different to MDCT (Mordi et al., 2017).  
Both DSE and MDCT together have high sensitivity in the diagnosis of CAD, but DSE alone has 
lower sensitivity but high specificity than MDCT (Nixdorff et al., 2008). Most patients with high 
CAC have normal wall motion during DSE (Ramakrishna et al., 2006).  
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Patients with diastolic dysfunction are more likely to have positive DSE, and obstructive CAD by 
MDCT (Mansour et al., 2017).  
In symptomatic patients with normal ECG and negative troponin, MDCT is more accurate than 
DSE to assess patient symptoms (Durand et al., 2017). DSE is superior to CMR in a chest pain 
assessment emergency department (Davies et al., 2016).  
In women who presented with chest pain, DSE is a more reliable and practical investigation 
compared to ETT in identifying CAD (Kim et al., 2016). DSE has high specificity and average 
sensitivity in detecting CAD in females (Geleijnse et al., 2007). In patients with left bundle branch 
block, DSE has more specificity than CMR in assessing CAD, but lower sensitivity mainly in 
patients with abnormal wall motion abnormalities at rest (Cortigiani et al., 2001, Sicari, 2009). 
There are more false positive DSE results in patients who developed systolic blood pressure >220 
mmHg during the test (Ha et al., 2002). Patients who had ST elevation during DSE has a higher 











The aim of this thesis is to assess symptomatic patients with typical chest pain, particularly those 
with typical angina. This thesis will compare the different levels of CAC by MDCT with the 
findings on ECG responses of the heart using ETT, myocardium perfusion using CMR, and heart 
muscle function in terms of wall motion abnormalities and other measures such as M-mode and 
tissue Doppler imaging (TDI) using DSE. Moreover, this work aims to evaluate the potential 
association between CAC assessed by MDCT with other non-invasive investigations, including 
ETT, CMR, and DSE in a group of symptomatic patients, irrespective of the presence of luminal 
stenosis. The list of thesis aims and hypothesis are listed below: 
Study 1 Aim (Chapter 3). This study aims to compare the diagnostic accuracy of MDCT with ETT 
for significant coronary artery disease in patients with typical chest pain.  
Study 1 Hypothesis (Chapter 3). This study hypothesises that MDCT is more accurate in 
identifying the presence and absence of significant coronary artery disease compared to ETT in 
patients with typical chest pain.  
Study 2 Aim (Chapter 4). This study aims to compare the diagnostic accuracy of MDCT with CMR 
for significant coronary artery disease in patients with typical chest pain.  
Study 2 Hypothesis (Chapter 4). This study hypothesises that MDCT is more accurate in 
identifying the presence and absence of significant coronary artery disease compared to CMR in 
patients with typical chest pain.   
Study 3 Aim (Chapter 5). This study aims to compare the diagnostic accuracy of MDCT with DSE 
for significant coronary artery disease in patients with syndrome X.  
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Study 3 Hypothesis (Chapter 5). This study hypothesises that MDCT is more accurate in 
identifying the presence and absence of significant coronary artery disease compared to DSE in 



























A retrospective study investigating 515 patients (360, 120, and 35 for ETT, CMR, and DSE 
respectively), (311 male, age 63 ± 8.4 years), presenting with angina-like symptoms to Bethanien 
Hospital Frankfurt, Germany between 2007 and 2010, or Umea Heart Centre, Umea, Sweden 
between 2009 and 2011, and had conventional risk factors assessed. From Umea medical centre 
and Bethanien hospital, patient data was collected from each hospitals database. Patients with a 
full data set, including CAC results, ETT results, CMR results at rest and stress, DSE results at 
rest and stress and full images and reports of invasive coronary angiography were used in this 
thesis. Patients with incomplete data were excluded. Umea medical Ethics Committee approved 
the study (see Appendix section) and Bethanien hospital’s Ethics Committee provided a waiver to 
use retrospective de-identified and anonymised patient data for the thesis. When performing 
routine clinical tests, patients provide signed informed consent to sign that they agree to being 
contacted with regard to clinical registries and future ethically approved research studies.  
All patients included were stable with a normal LV ejection fraction (>55%), RV size and diameter 
(<3.6 cm). The exclusion criteria included acute coronary syndrome patients, heart failure, valvular 
heart disease, thyroid and parathyroid diseases, inflammatory disease or chronic kidney disease 
(creatinine >130mmol/L). All patients subsequently underwent conventional coronary 
angiography, which was performed not more than one month after their ETT, MDCT, CMR, 
and/or DSE. The Judkin’s technique was used with at least four views of the left system and two 




Significant obstructive coronary disease was considered present when there was clear evidence for 
at least one vessel stenosis of ≥50% lumen narrowing on invasive angiography. Although it is 
acknowledged other researchers consider significant CAD when the stenosis is ≥70% on coronary 
angiography, we considered ≥50% as previously performed (Meijboom, W.B 2008; JACC 52; 
2135-44) and due to the fact that the majority of plaque ruptures and resultant MI’s occur in 
coronary arteries with <70% stenosis (Maddox, TM 2014 JAMA, 312; 1754-63). All patients age, 
gender, presence or absence of hypercholesterolemia, hypertension, diabetes, obesity, smoking 
history and family history of CAD was recorded.  
Interobserver variability was performed using SPSS to all the echo measurements during rest and 
stress. The interobserver variability is highly agreed with results between 0.81 and 1.0.  























                                                                     










                                                         
 
 





Patients referred to CMR  
(n= 120) 
Patients referred to ETT  
(n= 35) 
Patients referred to DSE 
(n=35) 
Patients with typical chest 
pain (angina like symptoms) 
and cardiac risk factor/s (n= 
515) 
Patients referred to ETT 
(n= 360) 
All patient referred to invasive 
coronary angiography                                                                                                                                                                                                                                                                                                                                                                                       
All patients refereed to 





Computed tomography was used to determine coronary calcium.  The scanner operated in the high-
resolution volume mode. All patients had sinus rhythm at the time of CT and none had renal failure, 
hyperthyroidism or allergy. CT was performed using a 64-detector-row scanner (Somatom 
Sensation Cardiac 64; Siemens Medical Solutions, Forchheim, Germany) (Figure 3) with a gantry 
rotation time of 330 ms (collimation 64 x 0.6 mm, reconstruction increment 0.3 mm). 
 
 
Figure 3: Somatom Sensation Cardiac 64; Siemens Medical Solutions, Forchheim, Germany. 
 
Image acquisition was performed during inspiratory breath-hold. To familiarize a patient with the 
protocol, breath-holding was practiced before the examination.  
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Patients whose heart rates were >60 beats/min received 5 mg bisoprolol or 50 mg of metoprolol 
orally 1 hour before CT examination. For an insufficient decrease in heart rate, up to 6 vials (30 
mg) of metoprolol was injected intravenously. The calcium scan was performed using prospective 
electrocardiographic triggering usually at 70% of the RR interval. The collimation was set to 30 x 
0.6 mm, and the reconstructed slice thickness was 3 mm (adapted field of view depending on heart 
size, matrix 512 x 512, pixel size usually 0.5 x 0.5 mm). Calcium was defined as the presence of 
>2 contiguous pixels with >130 Hounsfield Units.  
These lesions were automatically identified and marked in colour by the workstation. All lesions 
were added to calculate the total Agatston score (Becker et al., 2001), which was computed by 
summing the CACs of all foci in the epicardial coronary system (Matthew Budoff and Jerold 
Shinbane, 2016) (Figure 4). 
 
 
Figure 4: CAC and CT angiography for normal and sever calcified coronary arteries (182) 
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Recently, coronary CT angiography fractional flow reserve (FFRCT) is increasingly used in 
patients with coronary artery disease, and is likely to expand in the future with the use of coronary 
CT angiography as a first-line investigation in patients with suspected CAD. This technology was 
not available when the PhD data was collected. Invasive FFR has been shown as a useful technique 
to identify the probability of a coronary narrowing that hinds the myocardial ischemia. FFRCT is a 
non-invasive technique that calculating fluid dynamics to assess the physiological significance of 
CAD. It calculates the rest and hyperemic pressure fields in coronary arteries without modifying 
the protocols of the CT acquisition imaging, or adding any other images or medications. The 
FFRCT ratio obtained by dividing the mean pressure distal to the coronary stenosis by the mean 
aortic pressure (Koo et al., 2011, Kim et al., 2010). Patients with FFRCT ≤0.80 is considered 
positive for coronary ischemia, and may benefit from coronary revascularization. However, 
patients with FFRCT >0.80 can be treated medically (Nørgaard et al., 2018, Ihdayhid et al., 2019). 
There are many studies comparing the invasive FFR with the non-invasive FFRCT. 
Coronary angiography 
 
The Judkin’s technique was used with at least four views of the left system and two views of the 
right system. The decision to perform coronary angiography was not influenced by the CAC score 
but was based on the clinical assessment of the patient’s symptoms. Angiography was performed 
blindly within one month after the CT scan in all patients. Analysis of the coronary angiograms 
was performed by an independent experienced observer. Invasive coronary angiography was 




According to the AHA, the coronary arteries were segmented as the following: the right coronary 
artery (RCA) was divided in a proximal, middle, and distal parts; the left anterior descending artery 
(LAD) was divided into proximal, middle, and distal parts; the left circumflex artery (LCX) was 
divided into proximal and distal parts. Significant stenosis was defined as ≥50% lumen narrowing 
of any epicardial coronary artery.  
Exercise Tolerance Testing (ETT) 
 
All patients underwent exercise ECG using conventional treadmill method and Bruce protocol 
(Figure 5). ECG changes, blood pressure and symptoms were monitored throughout the test. There 
are seven stages of exercise, each stage of 3 minutes (maximum 21 minutes). In the first stage, the 
patient walks at 2.7 km up a 10% incline. Energy consumption is estimated to be 4.8 METs during 





Figure 5: Treadmill Stress ECG machine. 
 
The speed and incline increase with each stage. A 12-lead ECG was recorded during the test by 
the physiologist, before exercise (Figure 6), during peak exercise (Figure 7), and after the exercise 
during the recovery (Figure 8).  ST-segment was observed continuously during the test to check if 
there were any ST segment changes. The patient should achieve at least 85% of maximum heart 
rate, otherwise, the test is not conclusive.  
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Maximum heart rate is 220 minus age for men and 210 minus age for women (Hill and Timmis, 
2002). Each patient underwent ETT that was interpreted as positive when >1.5 mm ST depression 
after the J point (Ellestad and Wan, 1975).  
Exercise endpoints were chest pain or breathlessness, ischaemic ECG changes or arrhythmia. All 
our patients exercised for 9 mins or more, none of these patients had developed chest pain during 
the exercise, and all managed to reach the target heart rate. None of our patients were excluded 
due to developed chest pain before the 9 mins exercise. 
 
 






















Figure 8: 12 lead ECG after exercise (recovery). 
 
CMR perfusion scan 
 
CMR studies were performed using a 1.5 Tesla MRI system (Magnetom Sonata Maestro Class, 
Siemens AG, Erlangen, Germany) (Figure 9), with the patient in the supine position, and additional 
ECG electrodes connected with external system (Magnitude 3150, In Vivo Research Inc., Orlando, 






Figure 9: Magnetom Sonata Maestro Class, Siemens AG, Erlangen, Germany 
 
Blood pressure was also monitored. Both a six-channel body phased-array coil and a two-channel 
spine phased-array coil were used. Sequences acquired during breath-hold were performed during 
quiet expiration.  
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After localizers and anatomical images, perfusion imaging was performed. Typically, 3 short axis 
slices were acquired at the basal, mid papillary and apical levels of the left ventricle. Patients were 
stressed using a conventional adenosine protocol.  
Adenosine stimulates A2 receptors in the microvasculature, leading to relaxation of the arterioles. 
In normal myocardium, this leads to increased perfusion without changes in blood volume 
(Jayaweera et al., 1999). With coronary stenosis, the magnitude of the increased perfusion during 
vasodilation is compromised (Jayaweera et al., 1999).  
The pressure drops results in capillary closure and reduced perfusion and blood volume, which is 
demonstrated as slower arrival and lower contrast agent concentration in the ischaemic segment 
(Jayaweera et al., 1999). A single shot prospectively gated balanced Turbo Field Echo (TFE) 
sequence with a typical in-plane resolution of 2.5 x 2.5mm was used.  
Patients were then allowed to rest until the haemodynamic effects of the adenosine had subsided 
(typically 5 minutes). The location and distribution of myocardial perfusion defects in the left 
ventricle were described using the AHA 16 segment model (Cerqueira et al., 2002). For the stress 
study, intravenous adenosine was started 3 minutes before contrast injection.  
Twenty short-axis images were taken at every level of myocardium before, during and after 
contrast injection. Myocardial perfusion was measured during adenosine infusion using a high 
dose of Gadolinium-DTPA (0.06 mmol/kg).  
Adenosine was injected at a rate of 0.14 mg/kg/min, for 3–6 minutes for a total dose of 0.48 to 
0.84 mg/kg. To avoid the risk of large bolus drug, adenosine and contrast were administered 
through separate IVs (Gerber et al., 2008). Acquired images were subsequently transferred to a 
dedicated computer for analysing changes in the myocardial signal intensity (Cullen et al., 1999).  
53 
 
Two experienced observers reported results by the visual assessment of the myocardial perfusion 
and the blood supply of the 6 conventionally studied segments. Rest and adenosine stress scans 
were magnified and displayed at the same time for visual assessment (Hamon et al., 2010).  
In normal scans, the first pass into the myocardium changed its colour uniformly from black to 
grey. A slowly changing colour to grey suggested impaired perfusion and hence was considered 
as a perfusion defect either at rest or induced if it occurred at peak stress. The CMR system 
employed quantitative parametric tissue analysis (Jayaweera et al., 1999). Figure 10 details the 
comparison between MDCT perfusion and CMR perfusion during rest and during stress. During 
stress, there is perfusion defects in the basal inferior and infero-septal walls marked with the yellow 




Figure 10: Comparison between CT perfusion and CMR perfusion during rest and stress (Dweck 
et al., 2016) (Permitted from the author) 
 
 
According to the coronary angiography results, patients were divided into two groups: High Grad 
(HG) stenosis (≥50% stenosis) group (n=67, mean age 65.1±9.4 years) and no-HG stenosis (<50% 




The significant obstructive coronary disease was considered present when there was clear evidence 
for at least one HG stenosis with ≥50% lumen narrowing on the conventional angiogram. For 
compatibility the radiologists who analysed, interpreted and reported the CMR data have published 




All patients underwent rest and DSE. A Philips Intelligent E-33 system (Figure 11) with a multi-





Figure 11: Echocardiography, Philips Intelligent E-33 system. 
 
A standard protocol (McNeill et al., 1992) was used with dobutamine infusion, increasing every 3 
min with 10 μg/kg/min to a maximum dose of 40 μg/kg/min. If the target heart rate was not 
reached, atropine (0.25 mg - 2 mg) was used. The images were obtained with the patient in the left 
lateral decubitus position and during expiration.  
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Left ventricular (LV) segmental wall motion was assessed using a 17-segment model. A global 
wall motion score was calculated using the segmental scoring system (1 = normal, 2 = hypokinetic, 
3 = akinetic, 4 = dyskinetic). (Table 3). RWMAs considered when confirmed by a minimum of 
two expert (senior) reviewers.  
 
Table 3 The segmental scoring system 
Score: 
1 = Normal/Hyperkinetic: normal/increased systolic wall motion and thickening 
2 = Hypokinetic: decreased systolic wall motion and thickening 
3 = Akinetic: absent systolic wall motion and thickening 
4 = Dyskinetic: outward systolic wall motion and thickening 
 
 
With two-dimensional echocardiography from the four-chamber view, ventricular long axis 
motion was studied by M-mode with the cursor positioned at the LV septal (Figure 12, 13) and 
lateral (Figure 14, 15) annulus and recorded mitral annular plane systolic excursion (MAPSE) and 
then positioned at the RV free wall annulus (Figure 16, 17) to measure tricuspid annular plane 
systolic excursion (TAPSE). The total long-axis amplitude of motion was measured from the 
annular displacement between the outermost point at the onset of the Q wave and the innermost 
part shortly after the end of ejection. In addition, at the same sites, pulse wave myocardial tissue 
Doppler velocities were acquired to record systolic (s’) and early (e’) and late (a’) diastolic 
velocities. All M-mode and pulse-wave myocardial tissue Doppler velocity measurements were 









































































Tissue Doppler imaging assess myocardial motion linked to blood flow. Global and regional 
systolic and diastolic velocities can be displayed at rest and under stress. 
RV peak systolic and early diastolic velocities were measured. LV myocardial velocities were 
recorded using Tissue Doppler Imaging (TDI). With tissue Doppler, the velocities of myocardial 
segments can be measured. In tissue Doppler, the cursor is positioned over the tissue we want to 
examine. The probe will send pulses to the selected area, the pulses reflect with different 
frequency, and then the machine calculates the velocity of the reflection.  
During systole of the heart moves toward the apex (toward the probe), (s’) will appear above the 
baseline as it is positive and called systolic deflection, whereas, during diastole the heart base 
moves away from the apex (away from the probe), (e’) and (a’) will appear as two negative 
deflections below baseline (e’) and (a’) are equivalent to e/a of mitral filling.  
We measured systolic (s’) and early and late (e’ and a’) diastolic myocardial velocities in the lateral 
(Figure 18) and septal (Figure 19) segments of the LV, and at the RV free wall (Figure 20). 
 
In addition, we measured Peak LV and RV early (e wave), and late (a wave) diastolic velocities, 












































Dobutamine infusion was performed with an IVAC pump. Starting with a dose of 10µg/kg/min 
and increasing by similar increments every 3 minutes to a maximum of 40 µg/kg/min. Stress 
endpoints in controls were achieving 85% of the predicted target heart rate (220 minus age) or 
maximum Dobutamine dose. Atropine was used in some patients who did not reached the target 
heart rate after the maximum Dobutamine dose. Stress endpoints in patients were a development 
of symptoms (chest pain or breathlessness), systolic blood pressure decreased by 20 mmHg, 
ischaemic ECG changes such as ST changes or T wave inversion, and arrhythmia.  
Blood pressure (systolic and diastolic) was measured automatically at rest and at the end of each 
stage of stress. 12 lead ECG and oxygen saturation were recorded at the end of each stress stage.  
Tissue Doppler velocities of all the LV segments measured during stress and compared with rest. 
All the recruited patients complained of exertional angina-like symptoms, had >1mm ST shift on 
exercise test, but no obstructive disease on conventional angiography. All had normal LV ejection 
fraction (>55%), RV size and inlet diameter (<3.6 cm). All patients underwent DSE including M-
mode and tissue Doppler of LV and RV free wall, and CT CACS using a MDCT system. Based 
on CT findings patients were divided into Group I with CACS<100 and Group II with CACS >100.  
When patients are referred for DSE and the echo images are suboptimal due to lung problems or 
obesity, this may result in inaccurate assessment of LV function. As such contrast enhanced echo 
improves image quality and endocardial border definition during rest and stress. However, in this 
study, contrast was not available and as a result a number of studies were excluded due to poor 





Conventional risk factors  
 
A family history of premature CVD was defined as CAD in a first-degree relative (men <55 years 
and women <65 years). DM was defined as fasting glucose level of at least 126 mg/dl (7.0 mmol/l), 
use of hypoglycemic medications or self-reported previous physician diagnosis. Hypertension was 
defined as the use of antihypertensive medications or known but untreated hypertension. 
Dyslipidaemia was defined as the use of cholesterol-lowering medications or having known but 
untreated total serum cholesterol >200mg/dl (5.2 mmol/L). Current smokers and those who 
stopped smoking less than 30 days prior to the CT scan were included in the smoking category, 
whereas the remainder was characterized as non-smokers. Obesity was defined as body mass index 
(BMI) ≥30kg/m2, calculated from standardized measurements of height and weight.   
Statistics 
 
The statistical analysis was undertaken using a standard statistical software package (SPSS 18.0, 
SPSS Inc.). Categorical variables were expressed as an absolute number and percentage (%). 
Normally distributed continuous data were expressed as the mean ± standard deviation. The 
sensitivity, specificity and ratio comparison were analysed using Chi-square test. A p-value of less 
than 0.05 was considered statistically significant. Unpaired Student t-test was used to compare the 
difference between the two groups.  
Statistical measures of performance 
 
Sensitivity is a test, which measures the proportion of true positives (disease correctly identified) 




These measures provide the relative accuracy of an investigation when compared to the reference 
standard. Sensitivity is calculated by dividing the number of diseased patients who have positive 
tests by all the diseased patients and specificity is calculated by dividing the number of normal 
patients who have negative tests by the number of all the normal patients. The positive predictive 
value (PPV) is a positive test result and the patient truly has disease and the negative predictive 
value (NPV) is a negative test result and the patient truly does not have disease. PPV is calculated 
by dividing the number of diseased patients who have a positive test by the number of all the 
patients who have a positive test (true and false positive); however, the NPV is calculated by 
dividing the number of the non-diseased patients who have positive tests (false positive) by all the 
patients with a positive test. Ideally, measurements should be both accurate and precise. Both 
accuracy and precision reflect how close a measurement is to an actual value, but they are not the 
same. Accuracy reflects how close a measurement conforms to the correct value, whereas, 
precision reflects how close two or more measurements are to each other, regardless of whether 
those measurements are accurate or not. A Receiver Operator Characteristic (ROC) curve is a 
graphical plot used to show the diagnostic ability of binary classifiers, which is a plot of the 
sensitivity against the specificity for the different possible cut-points of a diagnostic test. The best 








Coronary calcium score is superior to exercise tolerance testing in predicting 





Coronary artery disease is one of the most common causes of death. Coronary calcium with CT 
scan measuring Agatston score, has been shown to be a reliable non-invasive investigation for 
screening patients with cardiac risk factors and for assessment of CAD. Coronary artery calcium 
detected with EBCT and MDCT is a sensitive marker of coronary artery calcifications. These scans 
measure the amount of calcium accumulated in the coronary arteries (Oudkerk et al., 2008, 
Agatston et al., 1990). The identification of CAC by MDCT or EBCT studies can be performed 
within 10 minutes (Budoff et al., 2006). CAC score increases with age and are known to be higher 
in males (McClelland et al., 2006). According to the ACC and the AHA guidelines, a heart scan 
by MDCT is generally not recommended for males under the age of 40 and females under the age 
of 50 (as it is unlikely to detect calcium at these age cut-offs), and to those who have low cardiac 
risk factors and people who are known to have CAD (Greenland et al., 2010). The severity of 
atherosclerosis is associated with the amount of calcium detected in the coronary arteries. A CAC 
score >400 is a severe form of coronary calcifications, and >1000 is very severe calcification 
(Azevedo et al., 2012). Calcium is not present in all the atherosclerotic plaque, therefore there is a 
possibility to find people with zero CAC and have obstructed CAD (Villines et al., 2011).  
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There is a recommendation from the American College of Cardiology Foundation/American Heart 
Association (ACC-AHA) guidelines to screen asymptomatic patients with intermediate risk of 
CAD (Greenland et al., 2010).  
On the other hand, ETT is a safe and inexpensive technique; however, it has limited positive 
predictive value for detecting CAD. During the exercise, if there are no ECG changes and there 
are no symptoms at maximum exercise, this indicates that the patient is less likely to have CAD. 
Any ECG changes with or without cardiac symptoms suggest a need for further investigations to 
confirm and determine the severity of CAD (Gershlick et al., 2007). The ACC-AHA guidelines 
recommend exercise ECG as the initial diagnostic test in patients at intermediate cardiac risk who 
are able to exercise (Fihn et al., 2012). Exercise-induced ST depression is a strong predictor of 
cardiac events (Mark et al., 1987). In patients with long-term cardiac risk factors, the CAC score 
by MDCT is the first line of investigation (Chang et al., 2015). Asymptomatic individuals with 
cardiac risk factors can be detected by the appearance of CAC, and positive ETT for those patients 
predicts cardiac events (Greenland et al., 2004). 50% of asymptomatic patients with a CAC of zero 
have less coronary events, even when they have a positive ETT. Patients with zero CAC score and 
positive ETT are more likely to have a false positive ETT result (Grossman et al., 2015). ETT has 
low sensitivity and specificity in predicting cardiac events in asymptomatic patients (Gibson, 
1991).   
In patients with cardiac chest pain, CAC is a trusted first investigation to rule out occluded CAD 
when compared to ETT and can be performed on all patients presenting with chest pain (Dedic et 
al., 2013). In stable patients with chest pain and intermediate cardiac risk factors, both CAC by 
MDCT and ETT investigations give high diagnostic accuracy in predicting CAD (Versteylen et 
al., 2013).  
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On the other hand, ETT is a safe and inexpensive technique; however, it has limited positive 
predictive value for detecting CAD. During the exercise, if there is no ECG change and there are 
no symptoms at maximum exercise, as detailed above, this indicates that the patient is less likely 
to have CAD. Any ECG changes with or without cardiac symptoms suggest a need for further 
investigations to confirm and determine the severity of CAD (Gershlick et al., 2007). The ACC-
AHA guidelines recommend exercise ECG as the initial diagnostic test in patients at intermediate 
cardiac risk who are able to exercise (Fihn et al., 2012). Exercise-induced ST depression is a strong 
predictor of cardiac events (Mark et al., 1987). In patients with long-term cardiac risk factors, the 
CAC score by MDCT is the first line of investigation (Chang et al., 2015). Asymptomatic 
individuals with cardiac risk factors can be detected by the appearance of CAC, and positive ETT 
for those patients predicts cardiac events (Greenland et al., 2004). 50% of asymptomatic patients 
with a CAC of zero have less coronary events, even when they have a positive ETT. Patients with 
zero CAC score and positive ETT are more likely to have a false positive ETT result (Grossman 
et al., 2015). ETT display low sensitivity and specificity in predicting cardiac events in 
asymptomatic patients (Gibson, 1991).  In patients with cardiac chest pain, CAC is a trusted first 
investigation to rule out occluded CAD when compared to ETT and can be performed on all 
patients presenting with chest pain (Dedic et al., 2013). In stable patients with chest pain and 
intermediate cardiac risk factors, both CAC by MDCT and ETT investigations give high diagnostic 








The aim of this study is to compare the sensitivity and specificity of CAC and ETT in predicting 
significant coronary artery stenosis in a group of symptomatic patients at intermediate risk of CAD.  
METHODS 
 
This was a retrospective study investigating 360 patients presenting with angina-like symptoms to 
Bethanien Hospital Frankfurt, Germany between 2007 and 2010, or Umea Heart Centre, Umea, 
Sweden between 2009 and 2011. Patients with chronic kidney disease (creatinine>130mmol/L or 
eGFR < 45 mL/min/1.73 m2), significant heart valve disease, heart failure, thyroid disease, 
parathyroid disease and severe inflammatory disease were excluded from the study. These patients 
underwent firstly ETT, then CT scanning for calcium scoring and finally conventional coronary 
angiography. All the patients had cardiac conventional risk factors assessed.  
Conventional risk factors  
 
Family history for premature disease was defined as CAD in a first-degree relative (men <55 years 
and women <65 years). Diabetes mellitus was defined as fasting glucose level of at least 126 mg/dl 
(7.0 mmol/l), use of hypoglycaemic medications or self-reported previous physician diagnosis. 
Hypertension was defined as the use of antihypertensive medications or known but untreated 
hypertension. Dyslipidaemia was defined as the use of cholesterol-lowering medications or having 
known but untreated total serum cholesterol >200mg/dl (5.2 mmol/L). Current smokers and those 
who stopped smoking less than 30 days prior to the CT scan were included in the smoking 
category, whereas the remainder was characterized as non-smokers. Obesity was defined as body 
mass index (BMI) ≥30kg/m2, calculated from standardized measurements of height and weight. 
75 
 
Intermediate risks factors can be assessed in primary health care and can suggest an increased risk 
of developing a heart attack, heart failure and other cardiac complications. 
Exercise Tolerance Testing (ETT) 
 
All patients underwent exercise ECG using conventional treadmill method utilizing the Bruce 
protocol. A positive exercise ECG was taken as >1.5 mm ST depression after the J point with more 
information in chapter “2”. 
Calcium screening 
 
Computed tomography was used to determine coronary calcium. The scanner operated in the high 
resolution volume mode. CT was performed using a 64-detector-row scanner (Somatom Sensation 
Cardiac 64; Siemens Medical Solutions, Forchheim, Germany), explained in detail in chapter “2”. 
Coronary angiography 
 
The Judkin’s technique was used with at least four views of the left system and two views of the 












The statistical analysis was undertaken using a standard statistical software package (SPSS 18.0, 
SPSS Inc.). Categorical variables were expressed as an absolute number and percentage (%). 
Normally distributed continuous data were expressed as mean ± standard deviation.  
The sensitivity, specificity and ratio comparison were analysed using Chi square test. As the two 
methods use same group of patients, the McNemar test was used. A p-value less than 0.05 was 





Table (4) shows the population characteristics of age, gender and coronary atherosclerosis risk 
factors (hypertension, dyslipidaemia, smoking, obesity, family history of CAD, and DM). The total 
population numbered 360 out of 515 patients, mean age 64.7±9.8years, 208 (59%) were males. 
There were 241 (67%) patients <70 years, and the remaining 119 (33%) patients were ≥70 years. 
Two thirds of the patients (68%) had hypertension and around 50% had dyslipidaemia and/or 
family history of CAD. We excluded all patients who did not have all the required data. Moreover, 
we excluded patients who had inconclusive ETT and/or MDCT results, and accordingly those who 
did not get referred for invasive angiography. The mean CAC score for the whole patient group 
was 295±561. There were 142 (39.4%) out of 360 patients who had a positive ETT, 70 of these 
were males. All the patients exercised ≥9 mins, and most of them reached the target heart rate.  
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Those who failed to reach their target HR had ST segment changes suggesting a positive ETT. All 
the ETT results were reviewed by two investigators and confirmed by Professor N. Patel (second 
supervisor). 
 




Percentage/mean age  +VE ETT  
Mean age 64.7±9.8    
Males 208 (57.8%)  70 (33.65%)  
Hypertension 246 (68.3%)  93 (37.8%)  
Hypercholesterolemia 190 (52.8%)  69 (36.31%)  
Smoking 106 (29.4%)  38 (35.84%)  
Obesity 103 (28.6%)  33 (32.0%)  
Family history 169 (46.9%)  63 (37.27%)  
Diabetes mellitus 38 (10.6%)  14 (36.84%)  
Mean CAC score 295±561    
 







Table 5 shows that the presence of CAC >0 had a sensitivity of 97% in predicting both ≥50% and 
≥70% CA stenosis and a sensitivity of 96% in predicting single- and multi-vessel disease (SVD 
and MVD). The negative (-ve) predictive value of the presence of CAC >0 for ≥50% CAD,  ≥70% 
CAD, single CAD and multiple CAD was 96%, 97%, 79% and 92%, respectively, but the 
specificity was generally poor.  
Compared to CAC >0, a CAC ≥400 had higher specificity for CA stenosis ≥50%, ≥70% and MVD 
(p<0.001) and for SVD (p=0.05) but lower sensitivity which fell to <50% (p<0.001 for CA stenosis 
≥50%, ≥70% and SVD; p=0.01 for MVD) and -ve predictive value, although only the difference 
in SVD was significant (p=0.01). ETT sensitivity was significantly lower for CAC >0 (p<0.001 
for CA stenosis ≥50%, ≥70% and SVD, p=0.01 for MVD) and not different from CAC ≥400 for 
all degrees of stenosis. 
ETT specificity was higher than CAC >0 (p<0.001 for CA stenosis ≥50%, ≥70% and MVD, p=0.62 
for SVD) but lower than for CAC ≥400 (p=0.015 and p=0.027 for CA stenosis ≥50% and ≥70%; 
SVD and MVD not significant), while the –ve predictive value was not significantly different from 










Table 5: The sensitivity and specificity for CAC and ETT to predict coronary stenosis (CS) 








CAC>0 (276) Sensitivity  97.2 (91.5-99.3) 97.4 (90.1-99.5) 96.3(91.1-98.6) 96.6 (87.2-99.4) 
Specificity  26.2 (20.6-31.7) 23.3 (18.6-28.8) 46.3 (40.1-62.4) 19.0 (13.1-28.2) 
Positive value  35.9 (30.5-41.8) 25.7 (20.9-31.2) 85.4 (78.6-90.4) 37.7 (30.1-46.0) 
Negative 
value  
95.6 (86.8-98.9) 97.1 (88.8-99.5) 79.2 (57.3-92.1) 91.7 (72.5-98.6) 
CAC≥400 
(84) 
Sensitivity  41.7 (32.4-51.6) 37.7 (27.1-49.4)) 42.5 (34.1-51.4) 45.8 (33.5-63.0) 
Specificity  84.5 (79.3-88.6) 80.6 (75.4-84.9) 92.7 (79.0-98.1) 71.6 (62.6-79.5) 
Positive value  53.6 (42.4-64.4) 34.5 (24.7-45.8) 95.0 (85.2-98.7) 45.0 (32.3-58.3) 
Negative 
value  
77.1 (71.6-81.8） 82.6(77.5-86.8） 33.0 (24.7-42.5) 72.2 (63.8-80.7) 
ETT positive Sensitivity  38.9 (29.8-48.8) 39.0 (28.3-50.8) 41.0 (32.7-49.9) 45.8 (32.0-58.4) 
Specificity  60.3(54.0-66.3) 60.4 (54.4-66.1) 56.1 (39.9-71.2) 60.3 (50.3-68.7) 
Positive value  29.6 (22.4-37.9) 21.5 (14.9-28.9) 75.3 (63.6-84.4) 37.0 (25.0-47.8) 
Negative 
value  












Figure 21: The Sensitivity (A) and Specificity (B) of CAC and ETT to predict CAD. A: CAC >0 
sensitivity is higher than CAC≥400 and ETT (p<0.01), CAC≥400 and ETT is not different. B: 
CAC >0 specificity is lower than CAC≥400 (p<0.01) and ETT (p<0.01) 
 
The effect of age on CAC and ETT in the prediction of CA stenosis (Table 6 
and figure 22): 
 
Comparison between CAC >0, CAC ≥400 and ETT within the two age groups: 
 
In patients aged ≥70, sensitivity for CAC >0 was higher than for ETT (p=0.009 for CA stenosis 
≥50%, p=0.045 for CA stenosis ≥70%, p=0.004 for SVD and p=0.08 for MVD) but not different 
between CAC >0 and CAC ≥ 400. Specificity is lower for CAC >0 than for both CAC ≥ 400 
(p<0.01 for all) and ETT (p<0.001 for CA stenosis ≥50%, ≥70% and MVD, p=0.04 for SVD), and 
there was no difference in specificity between CAC ≥400 and ETT.  




In patients aged <70y, the sensitivity for CAC >0 was greater compared to both CAC ≥400 and 
ETT (p<0.01 for CA stenosis ≥50%, ≥70% and SVD and p<0.05 for MVD), but there was no 
difference in sensitivity between CAC ≥ 400 and ETT. Specificity was generally lower for CAC 
>0 than for both CAC ≥400 and ETT (p<0.01 for CA stenosis ≥50%, ≥70% and MVD) except for 
SVD, where there was no difference, while specificity for ETT was lower than for CAC ≥400 
(p<0.01 for CA stenosis ≥50%, ≥70% and MVD, no difference for SVD). The –ve predictive value 
of CAC >0 was higher than for CAC ≥ 400 and ETT. 
 
Comparison between age ≥70 and <70: 
 
Compared to age <70, the sensitivity was higher in age ≥70 when using CAC ≥ 400 in predicting 
CA stenosis ≥50% (p=0.018), ≥70% (p=0.06), SVD (p=0.008) and MVD (p=0.039) but not when 
using CAC >0 and ETT. The specificity was lower in age ≥70 when using CAC >0 to predict CA 
stenosis ≥50% (p<0.001), ≥70% (p<0.001), SVD (p=0.052) and MVD (p=0.018), but not for CAC 
≥400 and ETT. The –ve predictive value was not different between age ≥70 and <70 for any 










Table 6: The sensitivity and specificity for CAC and ETT to predict coronary stenosis (CS) in 
patients above and those below 70 years 






Sensitivity  97.9 (97.3-99.9) 100 (87.0-100) 100 (82.2-100) 98.1 (88.4-99.9) 
 Specificity  5.6 (1.8-14.3) 5.8 (2.2-13.7) 5 (0.9-18.2) 9.1 (0.5-42.8) 
 Positive value  40.4 (31.4-50.0) 28.9 (21.0-38.3) 37.7 (25.9-51.1) 83.6 (71.5-91.4) 
 Negative value  80.0 (29.9-98.9) 100 (46.3-100) 100 (19.8-100) 50 (0.3-97.3) 
 CAC≥400 Sensitivity  61.7 (46.4-75.1) 57.6 (39.4-74.0) 73.9 (51.3-88.9) 65.4 (50.8-77.7) 
  Specificity  75 (63.2-84.1) 67.4 (56.4-76.9) 57.5 (41.0-72.6) 100 (67.9-100) 
  Positive value  61.7 (46.4-75.1) 40.4 (26.7-55.7) 50 (32.8-67.2) 100 (87.4-100) 
  Negative value  75 (63.2-84.1) 80.6 (69.2-88.6) 79.3 (59.7-91.3) 37.9 (21.3-57.6) 
 ETT positive Sensitivity  40.4 (26.7-55.7) 45.5 (28.5-63.4) 43.5 (23.9-65.1) 38.5 (25.6-53.0) 
  Specificity  66.7 (54.5-77.1) 67.4 (56.4-76.9) 67.5 (50.8-80.9) 72.7 (39.3-92.7) 
  Positive value  44.2 (29.4-60.0) 34.9 (21.5-51.0) 43.5 (23.9-65.1) 87 (65.3-96.6) 
  Negative value  63.2 (51.3-73.7) 76.3 (64.9-85.0) 67.5 (50.8-80.9) 20 (9.6-36.1) 
<70ys CAC>0 
 
Sensitivity  96.7 (87.6-99.4) 95.5 (83.3-99.2) 94.4 (83.4-99.9) 95.1 (87.3-98.4) 
 Specificity  33.9 (27.1-41.4) 31 (24.7-38.0) 26.3 (18.0-38.8) 60 (40.8-76.8) 
 Positive value  33.1 (26.4-40.6) 23.6 (17.7-30.6) 37.8 (28.0-48.7) 86.7 (77.5-92.6) 
 Negative value  96.8 (88.0-99.4) 96.8 (88.0-99.4) 90.9 (75.1-99.8) 81.8 (59.0-94.0) 
 CAC≥400 
 
Sensitivity  26.2 (16.2-39.3) 22.7 (12.0-38.2) 27.8 (15.2-46.5) 28 (19.0-39.2) 
 Specificity  88.3 (82.5-92.5) 86.3 (80.1-90.6) 78.9 (68.2-87.3) 90 (72.3-97.4) 
 Positive value  43.2 (27.5-60.4) 27 (14.4-44.4) 38.5 (20.9-59.3) 88.5 (68.7-97.0) 
 Negative value  77.9 (71.5-83.3) 83.3 (77.3-88.0) 69.8 (60.0-79.9) 31.4 (22.1-42.4) 
 ETT positive 
 
Sensitivity  37.7 (25.9-51.1) 34.1 (20.9-50.0) 47.2 (29.2-63.1) 42.7 (32.0-54.1) 
 Specificity  57.8 (50.2-65.0) 57.4 (50.1-64.3) 56.6 (44.1-66.9) 50 (31.7-68.3) 
 Positive value  23.2 (15.6-33.0) 15.2 (9.0-24.1) 34 (20.0-46.8) 70 (55.2-81.7) 














Figure 22: The Sensitivity and specificity of age≥70 (A, B) and age<70 (C,D) on CAC and ETT 






The effect of gender on CAC and ETT in the prediction of CA stenosis (Table 
7) 
Comparison between CAC >0, CAC ≥400 and ETT according to gender: 
 
In females, sensitivity for CAC >0 was higher than for CAC ≥400 (p<0.01 for CA stenosis ≥50%, 
≥70% and SVD, p=0.11 for MVD) but not different from ETT and there was no difference in 
sensitivity between CAC ≥400 and ETT. Specificity for CAC >0 was lower than for CAC ≥400 
(p<0.01 for CA stenosis ≥50%, ≥70% and MVD, p=0.1 for SVD) and modestly lower than for 
ETT (p<0.05 for CA stenosis ≥50% and ≥70%, p=0.76 for SVD, p=0.10 for MVD). CAC ≥400 
had higher specificity than ETT in predicting CA stenosis ≥50% and ≥70% (p<0.01 for both) but 
not for SVD or MVD. In males, sensitivity for CAC >0 was higher than for both CAC ≥400 and 
ETT (p<0.01 for CA stenosis ≥50%, ≥70% and SVD, p<0.05 for MVD) but specificity for CAC>0 
was lower than for CAC ≥400 and ETT in predicting CA stenosis ≥50%, ≥70% and MVD (p<0.001 
for all) but not for SVD. Neither sensitivity nor specificity were different between CAC ≥400 and 
ETT and the –ve predictive value was similarly unchanged between CAC >0, CAC ≥400 and ETT 
for all categories except SVD. CAC >0 had higher -ve predictive value than CAC ≥400 (p=0.02) 
and ETT (p=0.001). 
 
Comparison between females and males: 
 
Table 7 shows that the sensitivity between females and males was not different for all categories 
of stenosis for CAC >0, CAC ≥400 and ETT. Compared to females, males had lower specificity 
in predicting CA stenosis ≥70% (p=0.02) when considering CAC >0 and had a lower -ve predictive 




Table 7: The sensitivity and specificity for CAC and ETT to predict coronary stenosis (CS) in 















CAC>0 Female Sensitivity  93.5 (77.2-98.9) 95.2 (74.1-99.8) 90.9 (57.1-99.5) 91.9 (77.0-97.9) 
Specificity  33.1 (24.9-42.2) 31.3 (23.6-40.1) 28.3 (18.4-43.8) 48.1 (29.2-67.6) 
Positive value  26.4 (18.6-35.8) 18.2 (11.7-26.9) 20.8 (10.9-35.4) 70.8 (55.7-82.6) 
Negative value  95.2 (82.6-99.2) 97.6 (85.9-99.8) 93.8 (69.2-99.7) 81.3 (53.7-95.0) 
Male Sensitivity  98.7 (92.0-99.9) 98.2 (89.2-99.9) 97.9 (87.5-99.9) 97.9 (92.0-99.6) 
Specificity  19.1 (12.9-27.1) 16.4 (11.1-23.5) 11.1 (5-22.2) 42.9 (18.8-70.4) 
Positive value  41.8 (34.6-49.3) 30.2 (23.8-37.5) 45.6 (35.9-55.7) 92.2 (84.8-96.3) 
Negative value  96.2 (78.4-99.8) 96.2 (78.4-99.8) 87.5 (46.7-99.3) 75 (35.6-95.5) 
CAC≥400 Female Sensitivity  29 (14.9-48.2) 19 (6.3-42.6) 27.3 (8.1-64.6) 29.7 (16.4-27.2) 
Specificity  95 (89.1-98.0) 91.6 (85.1-95.5) 83.0 (70.2-91.6) 96.3 (76.1-99.8) 
Positive value  60 (32.9-84.5) 26.7 (8.9-55.2) 25 (6.7-57.2) 91.7 (59.8-99.6) 
Negative value  83.9 (76.5-89.5) 87.6 (80.6-92.4) 84.6 (73.6-93.9) 50 (36.0-64.0) 
Male Sensitivity  46.8 (35.4-58.4) 44.6 (31.6-58.4) 50 (35.4-64.6) 47.4 (37.3-57.8) 
Specificity  74.8 (66.3-81.8) 71.1 (63.1-78.0) 61.9 (48.8-73.6) 85.7 (56.2-97.5) 
Positive value  52.2 (39.9-64.2) 36.2 (25.3-48.8) 50 (35.4-64.6) 95.8 (84.6-99.3) 
Negative value  70.5 (62.1-77.8) 77.7 (69.7-84.1) 61.9 (48.8-73.6) 19 (10.6-31.3) 
ETT 
positive 
Female Sensitivity  54.8 (36.3-72.2) 57.1 (34.4-77.4) 81.8 (41.8-96.8) 59.5 (44.2-74.8) 
Specificity  54.5 (45.3-63.5) 54.2 (45.3-62.9) 52.8 (38.8-66.5) 55.6 (35.6-74.0) 
Positive value  23.6 (14.7-35.3) 16.7 (9.3-27.7) 26.5 (13.5-44.7) 64.7 (46.5-79.9) 
Negative value  82.5 (72.0-89.8) 88.8 (79.2-94.4) 93.3 (76.5-98.8) 50 (31.7-68.3) 
Male Sensitivity  32.5 (22.5-44.2) 32.1 (20.6-46.1) 37.5 (24.3-52.7) 34 (24.9-44.4) 
Specificity  65.6 (56.8-73.6) 65.8 (57.6-73.2) 66.7 (53.6-77.7) 57.1 (29.6-81.2) 
Positive value  35.7 (24.9-48.1) 25.7 (16.3-37.8) 46.2 (30.4-62.6) 84.6 (68.8-93.6) 
Negative value  62.3 (53.6-70.3) 72.5 (64.1-79.6) 58.3 (46.1-69.6) 11.1 (5.3-21.3) 
86 
 
ROC curve analysis for prediction of CA stenosis (Figure 23): 
 
The optimum cut-off value for CAC in predicting ≥50% CA stenosis was 46.5, giving an area 
under the curve (AUC) of 76%, a sensitivity of 83% and specificity of 62% (p<0.001). Exclusion 
of patients with extensive calcification (CAC >1000) resulted in a sensitivity of 81%, specificity 
of 53% and AUC of 71.1%.  
  
 
Figure 23: ROC Curve showing the highest sensitivity and specificity for prediction of coronary 
artery stenosis 
 
CAC 0 = the analysis includes all patients. AUC=0.763, cut-off = 46.5, sensitivity = 83.3%, specificity = 
61.9%. 
CAC 400 = the analysis includes patients with CAC ≥ 400. AUC=0.706, cut-off = 46.5, sensitivity = 85.7%, 
specificity = 48.7%. 
CAC 1000 = the analysis includes patients with 0<CAC<1000. AUC=0.711, cut-off = 46.5, sensitivity = 






In our symptomatic group of patients, the results show that a CAC score of 46.5 is the best predictor 
of the presence of significant CA stenosis, having a sensitivity of 83% and specificity of 62%. This 
accuracy is irrespective of whether severity of CA stenosis was taken as ≥50% or ≥70%. In 
addition, ETT proved to be the poorer predictor of CA stenosis, except for its high -ve predictive 
value in predicting multi-vessel disease. In the study population the fact that a CAC score of 46.5 
is the best predictor of severe CA stenosis is remarkable for two reasons. Firstly, it is a relatively 
low score; many individuals above the age of 65 would have a similar, if not a higher score. 
Secondly, the conventional approach is to take a CAC score of ≥200 as a significant marker for 
CA stenosis. In addition, our study shows definitively that severe CA stenosis does not equate to 
a severe CAC.  
Analysis of age showed that for CAC scores >0 and ≥400, age ≥70 gives a more accurate sensitivity 
but lower specificity, while -ve predictive values are not different between age groups. For ETT, 
age ≥70 gives a marginally higher sensitivity and specificity but lower –ve predictive value. 
Furthermore, analysis of gender showed that for a CAC score >0, there was little difference 
between results for males and females but for a CAC score ≥400, accuracy for males was higher 
for sensitivity but lower for specificity and –ve predictive value. Similarly, for ETT, accuracy in 





Data Interpretation  
In this study, two non-invasive methods of predicting significant CA stenosis were compared in a 
group of symptomatic patients. CAC is an anatomical pathology which is considered as a marker 
of subclinical atherosclerosis.  
Although it is well known that not all plaques become calcified, in most cases plaques are ‘mixed’ 
type (partly calcified and partly un-calcified). We managed to demonstrate a moderately close 
relationship between the presence of CAC and coronary stenosis, although evidence exists 
showing that in some forms of atherosclerotic CA disease this association does not exist, such as 
in acute coronary syndrome, where a significant percentage of patients have no evidence of CAC 
on the culprit lesion (Henneman et al., 2008, Schuijf et al., 2009). It is possibly that these lesions 
were calcified, but by very small micro-particles of calcium, which cannot feasibly be measured 
by the conventional Agatston score.  
On the other hand, evidence also exists that patients with stable angina might present with severe 
calcification but no flow-limiting lesions (Nicoll and Henein, 2010), as was the case with some of 
our patients. Studies consistently show that patients with extensive calcification have a lower 
probability of acute coronary syndrome compared to those with zero CAC (Nicoll and Henein, 
2013). 
CAC presence and extent is known to correlate with cardiac events and all-cause mortality 
(Rennenberg et al., 2009, Polonsky et al., 2010, Budoff et al., 2010), and can approximate the total 
atherosclerosis plaque burden (Mieres et al., 2007), although not all studies found a close linear 




As with ours, most studies show a very high sensitivity but poor specificity of the CAC score for 
angiographic obstructive disease (Greenland et al., 2007, Budoff and Gul, 2008, Simons et al., 
1992, Ardehali et al., 2007, Nieman et al., 2009b), possibly because of arterial remodelling. This 
has led several authors to conclude that CAC screening in stable symptomatic patients is a reliable 
means of excluding obstructive CAD (Nieman et al., 2009b). Even in asymptomatic patients, 
Geluk et al (2007) found that CAC was significantly more reliable than ETT in predicting ≥50% 
CA stenosis. 
On the other hand, ETT is a functional test, the value of which is based on the demonstration of 
electrical evidence for myocardial ischaemia. It is the most commonly used investigation in open 
access chest pain clinics, as well as in post-myocardial infarction prognosis clinics (Sami et al., 
1979). Our results show that ETT has significantly lower sensitivity and specificity in predicting 
significant CA stenosis compared to CAC. This of course does not refute the significant value of 
ETT in providing good prognostic value in patients with multi-vessel CAD (Bartel et al., 1974). 
Since it is based on the assessment of overall cardiac muscle function and its response to severity 
of ischaemia rather than simply the presence of calcium deposition in the arterial wall, therefore it 
seems that the two investigations should be seen as complimentary rather than in competition.  
Despite the fact that ETT has long been used in the work-up of patients with suspected CAD 
(Greulich et al., 2012) and is prediction of cardiac events (Versteylen et al., 2013, Dedic et al., 
2011), a number of recent large studies have failed to show a strong predictive value in 
symptomatic intermediate risk patients, with ETT having between a 30%-50% sensitivity to detect 
≥50% stenosis (Greulich et al., 2012, Blankstein et al., 2012, Maffei et al., 2010a, Maffei et al., 




Only one study has shown a sensitivity of 71% for ≥50% stenosis (Lewis et al., 2005), while in 
another, sensitivity increased to 83% for detection of ≥70% stenosis (Blankstein et al., 2012); we 
found sensitivity to predict ≥70% narrowing remained at 39%. ETT specificity varies wildly, with 
study results ranging between 17% and 93% for detection of ≥50% stenosis (Bartel et al., 1974, 
Blankstein et al., 2012, Lewis et al., 2005, Larghat et al., 2013, Nieman et al., 2009a) we found 
specificity of 53.7%. A meta-analysis showed that ETT was more useful at excluding CAD than 
predicting it but a positive test may be more predictive in younger patients (Banerjee et al., 2012).  
ETT is also known to be generally less accurate in women (Mieres et al., 2005). A meta-analysis 
showed that in women ETT had sensitivity of 61% (vs 72% in men) and specificity of 70% (vs 
77% in men), although the –ve predictive value is high for ETT (Gibbons et al., 2002).  
Our findings, however, showed that sensitivity was more accurate in women than men (54.8% vs 
32.5%) for prediction of ≥50% stenosis and ≥70% stenosis (57.1% vs 32.1%).  
Where predictive accuracy of ETT is compared against other imaging techniques, magnetic 
resonance imaging stress testing and stress echocardiography proved to be significantly more 
accurate (Banerjee et al., 2012, Greulich et al., 2012). 
Clinical implications  
Although our results clearly show that CAC screening is a better predictor of coronary stenosis 
than ETT, we find that the using of the two methods together, is better than either alone, since one 




Particularly in symptomatic patients with extensive CAC, we illustrated that ETT might be more 
informative in confirming myocardial ischaemic as an explanation of symptoms than a coronary 
angiogram which might not show any significant stenotic lesions and may give false reassurance.  
 
Conclusions  
Coronary calcification and exercise stress testing provide different information with regards to the 
presence of CA stenosis. While calcification is more sensitive in predicting its presence, exercise 
testing is more accurate in excluding it. The two tests then should be seen as complementary rather 




















A myocardial perfusion scan assesses blood flow to the myocardium, and it is a gold standard 
cardiac non-invasive investigation for assessing cardiac function. CMR is used to detect 
myocardial ischaemia with a high diagnostic accuracy, and it used to evaluate rest and stress 
perfusion (Greenwood et al., 2012). In patients with triple vessels disease, CMR is more accurate 
than SPECT in identify CAD (Schwitter et al., 2012, Keijer et al., 2000). During stress CMR, 
myocardial perfusion, and left ventricular contractility are assessed (Nagel et al., 1999). The 
sensitivity of CMR perfusion in identifying CAD increased with both MDCT and CMR together, 
whereas the specificity slightly decreased from 88% to 83%. In general, the combination of CMR 
and MDCT are more accurate than CMR alone in the diagnosis of CAD (Falcão et al., 2013). In 
patients with an inconclusive MDCT result, CAD can be ruled out by stress CMR (Sicari et al., 
2007). One of the important advantages of CMR is that it does not use ionizing radiation. There is 
an expectation that the use of CMR would reduce the requirements and the demand of invasive 
coronary angiography (Hartlage et al., 2012). There is an association between a negative stress 
CMR perfusion scan and very good two years prognosis with no major cardiac events (Nandalur 






The aim of this study was to evaluate the relationship between CAC assessed by MDCT and 
myocardial perfusion assessed by CMR in a group of symptomatic patients. 
Methods 
 
This is a retrospective analysis of 120 patients (mean age 65.1±8.9 years, 88 males) who presented 
with typical chest pain, defined as consistent exertional chest discomfort, to Bethanien Hospital, 
Frankfurt, Germany, between 2007 and 2010 and who underwent firstly CAC scoring using 
MDCT followed by myocardial perfusion scanning using CMR for those patients with persistent 
chest pain and who had inconclusive MDCT results. All patients subsequently underwent 
conventional coronary angiography. Invasive coronary angiography was performed not more than 
one month after the MDCT and CMR perfusion scans. None of the patients had acute coronary 
syndrome, heart failure, significant valvular heart disease, thyroid and parathyroid diseases, 
inflammatory disease or chronic kidney disease (creatinine>130mmol/L). Significant obstructive 
coronary disease was considered present when there was clear evidence for at least one high grade 
(HG) stenosis with ≥50% lumen narrowing on the conventional angiogram. According to the 
coronary angiography results, patients were divided into two groups: HG stenosis group (n=67, 






CMR perfusion scan 
 
CMR studies were performed using a 1.5 Tesla MRI system (Magnetom Sonata Maestro Class, 
Siemens AG, Erlangen, Germany). The location and distribution of myocardial perfusion defects 
in the left ventricle was described using the AHA 16 segment model (Cerqueira et al., 2002).  
Intravenous adenosine was started 3 minutes before contrast injection. Twenty short-axis images 
were taken at every level of myocardium before, during and after contrast injection (Gerber et al., 
2008). Rest and adenosine stress scans were magnified and displayed at the same time for visual 
assessment (Hamon et al., 2010). In normal scans, the first pass into the myocardium changed its 
colour uniformly from black to grey. A slowly changing colour to grey suggested impaired 
perfusion and hence was considered as a perfusion defect either at rest or induced, if it occurred at 
peak stress (Cullen et al., 1999). More details are available in chapter “2”. 
Coronary artery calcium (CAC) score 
 
CAC was measured using a 64 MDCT (Somatom Sensation Cardiac 64; Siemens Medical 
Solutions, Forchheim, Germany). The individual lesion scores were automatically summed to 
calculate the total Agatston score for each of the epicardial coronary artery territories as well as 
for the total coronary tree. Technique explained in detail in chapter “2”. 
Coronary angiography 
 
The Judkin’s technique was used with at least four views of the left system and two views of the 






A standard statistical software package (SPSS 20, IBM, Armonk, NY, USA) was used for the 
statistical analyses. Categorical variables were expressed as absolute number and percentage (%). 
Normally distributed continuous data were expressed as mean ± standard deviation.  
The  comparison between HG stenosis and no-HG stenosis group was analysed using Chi square 
test. The Spearman Rank Correlation was used to define the correlation between different CAC 
levels and myocardial perfusion on CMR. The null hypothesis was rejected on p-values <0.05. 
Result 
Of 120 patients, there were 67 in the group with high-grade stenosis and 53 in the group with no 
high-grade stenosis, based on invasive coronary angiography. Coronary risk factor distribution in 
the total study population and subgroups are listed in Table 8. The cardiovascular risk factors did 
not differ between the two groups, except for a higher proportion of males in the HG lesions group 









Table 8: Risk factor distribution in the total study population divided into those with HG stenosis 
and no HG stenosis 








Males, n (%) 













Hypertension, n (%) 45(37.5) 24(35.8) 21(39.6) 0.669 
Smoking, n (%) 18(15.0) 11(16.4) 7(13.2) 0.625 
Diabetes, n (%) 14(11.7) 8(11.9) 6(11.3) 0.916 
Obesity, n (%) 3(2.5) 1(1.5) 2(3.8) 0.427 
Family history of CVD, n (%) 




















CMR perfusion between HG-stenosis and no HG-stenosis (Table 9 and figure 
24): 
 
50% percent (60 patients) had CMR perfusion defect, either at rest or stress. Perfusion defect at 
rest indicate the high possibility of the presence of coronary HG-stenosis. The percentage and 
number of perfusion segments were significantly higher in patients with HG stenosis with more 
than 1 segment perfusion defect at rest (p=0.014) but there was no difference with stress (p=0.83).  
This implies that the more segments showing perfusion defect, the more patients had HG stenosis. 
In contrast, at peak stress there was no relationship between the number of segments with the 
perfusion defect and HG stenosis by conventional coronary angiography. 
Thirty four patients had myocardial perfusion abnormalities at rest and twenty six patients 
developed perfusion defects with stress. Stress-induced myocardial perfusion defects were 22.4% 
sensitive and 79.2% specific for detecting HG coronary stenosis. Combining resting and stress 











Table 9: The difference in myocardial perfusion between the two groups at rest and with stress 
 
 CMR perfusion defect (n, %) 
 0 segment > 1 segment p-value 
At rest    
HG stenosis 42 (62.7) 25 (37.3) 0.014 
No HG stenosis 44 (83.0) 9 (17)  
At stress    
HG stenosis 52 (77.6) 15 (22.4) 0.83 






Figure 24: The difference in myocardial perfusion between the two groups at rest and with stress 
 
CAC score between HG stenosis and no-HG-stenosis (Table 10 and figure 25 
and 26): 
 
There was a significant different between the two groups with a lower CAC score in patients with 
no-HG stenosis and a higher CAC score in those with HG stenosis (p<0.0001). On the ROC curve, 
the CAC cut-off value of 293 had a sensitivity of 71.6% and specificity of 83% in predicting HG 
coronary stenosis, giving an area under the curve of 0.80 (p-value <0.0001).  
Using the Chi-square test, the p-value of <0.0001 means that the CAC distribution between HG 
stenosis and No HG-stenosis are significantly different. Our purpose here is only to see the CAC 
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Table 10: The difference in CAC between the two groups 
  CAC (n)  
  0-99 100-399 400-999 ≥1000 Total 
HG stenosis 12 12 20 23 67 
No HG-stenosis 29 17 4 3 53 




Figure 25 showed the different cut-off points of CAC and their relations to the presence or absence 
of significant CAD by invasive coronary angiography. We noticed that those who have >0 CAC 
have more patients with significant CAD. Also, the cut-off point of 400 shows that the higher the 
















Figure 26: The ROC curve for calcium score to predict the CAD, AUC=0.80 (95% CI 0.82-0.88, 











CAC or/and myocardial perfusion in predicting HG coronary stenosis: 
 
A CAC score of 293 or the presence of at least 1 segment showing a myocardial perfusion 
abnormality was 74.6% sensitive and 71.7% specific in detecting HG stenosis. The respective 
values for the two abnormalities combined were 19.4% sensitivity and 90.6% specificity. 
CAC score versus CMR myocardial perfusion (Table 11, and 12): 
 
As shown in table 11, the severity of CAC correlated with the extent of myocardial perfusion in 
the patient group as a whole with stress (r=0.22, p=0.015), particularly in patients with no-HG 
stenosis (r=0.31, p=0.022). A CAC score cut-off value of 293 was 31.6% sensitive and 87.3% 
specific in detecting myocardial perfusion abnormalities. CAC score >0 was associated with a 
higher incidence of CMR perfusion defect compared to CAC score = 0. Furthermore, CAC >1000 
was associated with higher incidence of CMR perfusion defects compared to a CAC score <1000 
with stress, but not with CAC score > 0 or < 400 either at rest or stress.  
 
Table 11: The relationship between CAC level and the number of segments showing myocardial 
perfusion, particularly in patients with no HG stenosis 
 Rest  Stress 
All  r=0.066 p=0.476  r=0.221 p=0.015 
HG-stenosis r=0.049 p=0.696  r=0.189 p=0.125 






Table 12: CAC with variable cut off points and the CMR perfusion segments defects 
 



















 0 segments  32 20  18 16 
 1 segment  2 4  5 7 
 2 segments  1 2  1 2 
 > 3 segments  6 3  0 1 
        
Defect only at stress       
 0 segments 37 21 20 16   
 1 segment 1 4 1 3 0.236 0.042 
 2 segments 1 2 2 5   
 > 3 segments 2 2 1 2   
  
Defect either at rest or at stress  






 1 segment 13 7 4 5 
 2 segments 14 6 3 1 









CMR myocardial perfusion has been shown to have high accuracy in detecting coronary artery 
disease and related events (Nandalur et al., 2007, Gargiulo et al., 2013, Nagel et al., 1999, Falcão 
et al., 2013, Sicari et al., 2007, Hartlage et al., 2012, Takahashi et al., 2004, Schwitter et al., 2012, 
Keijer et al., 2000). This has been superseded by the greater accuracy of MDCT in excluding 
significant CAD (Schuijf et al., 2006).  
In fact, a subgroup of patients with either severe calcification but no HG stenosis or with impaired 
myocardial perfusion but no HG stenosis remains a clinical dilemma. There is currently no study 
that has shown an ideal way of describing these patients or proposed a strategy for managing them. 
The purpose of this study was to assess the relationship between CAC and CMR myocardial 
perfusion in patients with insignificant coronary stenosis.  
Findings  
Our study results concur with some of the above findings in showing only a modest relationship 
between the presence of HG stenosis and myocardial perfusion abnormalities by CMR. On the 
other hand, the CAC score was much more sensitive and specific in detecting HG stenosis, giving 
an area under the ROC curve of 80%.  
In addition, our findings highlight the relationship between CAC and stress myocardial perfusion 
defects, with an incremental increase in the number of myocardial segments showing perfusion 




This suggests potential development of myocardial ischaemia and symptoms associated with 
arterial wall hardening rather than luminal narrowing by a stenosis, suggesting that the CAC score 
might be reflecting the extent of plaque burden, irrespective of luminal narrowing (Bajraktari et 
al., 2013). We believe that we are the first to demonstrate that extensive CAC correlates with the 
diffuse pattern of myocardial perfusion defect in the absence of significant coronary stenosis, again 
suggesting association between a perfusion defect and arterial hardening. Pellika et al (2006) had 
shown a relationship between CAC and left ventricular wall motion abnormalities using stress 
echo but made no comment on the extent of obstructive lesions. We too have recently shown 
parallel subendocardial abnormalities at peak stress in symptomatic patients with no coronary 
stenosis, particularly in those with significant calcification (Palmerini et al., 2014).  
This evidence suggests that CAC, particularly with high scores, is likely to be associated with 
compromise coronary blood flow reserve and hence myocardial perfusion at the time of increased 
demand (peak stress).  
 
Clinical implications  
The coronary calcium score remains more accurate in detecting HG luminal stenosis over and 
above myocardial perfusion defects by CMR. Absolute reliance on luminal narrowing by either 
MDCT or conventional coronary angiography is likely to miss an important group of patients with 
limiting angina who do not demonstrate evidence for HG stenosis but suffer from wall hardening 





This finding suggests an important role for the routine measurement of the CAC score in angina 
patients, particularly those with unexplained symptoms by conventional angiography. 
 
Limitations  
There was a gender difference between patients with HG stenosis and those without, but this does 
not seem to have influenced our results, since the relationship between CAC and CMR myocardial 
perfusion defects was shown in those with no-HG stenosis, negating the potential imbalance of 
males, who generally have higher incidence of CAC (Erbel et al., 2008). Assessment of CMR 
perfusion was semi-quantitative but followed the international recommendations (Dweck et al., 
2016). This study was retrospective in its design therefore subject to potential bias in patient 
selection. A larger sample size would have strengthened the relevance of our findings, particularly 
with the subgroup of patients with extensive calcification who showed clear evidence for 
myocardial perfusion abnormalities. We relied in our data interpretation on the accuracy of the 
CAC measurements as previously reported by Achenbach et al (2001) who showed non-significant 
results in the variability of repeating CAC measuring by EBCT as well as the known low variability 
of the system we used 64-MDCT (Horiguchi et al., 2008). Further investigation of coronary flow 
such as Fractional Flow Reserve (FFR) is required for an accurate assessment of the coronary flow 
and confirm the severity of coronary stenosis. However, this information is not available.  
Finally, we did not assess MRI reproducibility, having considered the long experience of the 





In a group of patients with exertional limiting angina, coronary calcification is more accurate in 
detecting high grade luminal stenosis than myocardial perfusion defects. In addition, in patients 
with no stenosis the incremental relationship between coronary calcium score and the extent of 
myocardial perfusion suggests association with coronary wall hardening as an additional 
mechanism for stress-induced angina other than luminal narrowing. Also, there is an association 
between a perfusion defect and HG stenosis in patients with previous MI. These preliminary 
findings might have a clinical impact on management strategies of these patients other than 


















Effect of coronary calcium score on left and right ventricular response to 





Cardiac syndrome X is typical chest pain with evidence of myocardial ischaemia but in the absence 
of flow-limiting CAD on angiography. The physiological mechanism(s) of syndrome X remain 
unclear and the optimum management of this patient population remains a clinical challenge 
(Agrawal et al., 2014). Myocardial bridging is when the epicardial coronary vessel enter down into 
the myocardium, it is associated microvascular endothelial dysfunction in those patients with non-
obstructive CAD, and it is investigated by intravascular ultrasound. Endothelial dysfunction is 
characterised by a decrease in epicardial coronary artery diameter >20% after intracoronary 
acetylcholine, microvascular dysfunction when the index of microcirculatory resistance ≥25. (Sara 
et al., 2020, Pargaonkar et al., 2019). Since patient symptoms are usually exertional and one of the 
diagnostic criteria of the syndrome is 1 mm ST depression on exercise ECG, exercise treadmill 
testing is routinely used to assess functional capacity and to better understand the mechanisms of 
symptoms (Jadhav et al., 2006). Some patients who present with angina-like symptoms and have 
no signs of obstructive CAD usually have non-cardiac disease such as gastrointestinal or 
psychiatric disorders (Crea and Lanza, 2004). Other syndrome X patients may present with 




Such co-morbidities can limit a patient’s ability to perform an exercise treadmill test. Dobutamine 
stress echocardiography is a useful functional assessment for CAD in patients unable to exercise.  
Assessing myocardial function at rest and during stress using echocardiography, including M-
mode and tissue Doppler analysis, is a useful tool for the assessment of myocardial ischaemia 
through the assessment of stress induced wall motion abnormalities. There is association between 
RWMA and cardiac risk factors, such as obesity, hypertension, and male gender. Most patients 
who have high CAC have resting RWMAs (Agrawal et al., 2014). When assessing subclinical 
CAD individuals, a RWMA is more possible in those who have high CAC (Tsao et al., 2011). 
A meta-analysis of 55 studies including 3,714 patients, demonstrated that DSE has a sensitivity of 
81% and specificity of 84% in identifying CAD (Heijenbrok-Kal et al., 2007). Based on >11000 
patients, a normal stress echocardiogram gives an annual risk of 0.4–0.9% (Metz et al., 2007) and 
importantly, DSE has a higher specificity than ETT in predicting CAD (Tsao et al., 2011). 
Prior research has demonstrated that there is a significantly elevated risk of adverse cardiac events 
in syndrome X patients with non-obstructive coronary artery disease compared to syndrome X 
patients with normal coronary arteries.  
However, no study has examined the association of coronary calcium score with DSE outcomes 
in syndrome X patients with non-obstructive coronary artery disease. Therefore, the aim of this 
study is to compare resting and stress echocardiography parameters with coronary artery calcium 










We examined thirty-five patients with Syndrome X (24 female, mean age 62 years), who 
complained of exertional angina like symptoms, had ≥1mm ST shift on exercise test but no 
obstructive disease on conventional angiography.  
No patient had a prior coronary event, coronary intervention, significant valvular heart disease, 
heart failure or atrial fibrillation. All patients had normal LV ejection fraction (>55%), RV size 
and inlet diameter (<3.6 cm). Patients underwent DSE including M-mode and tissue Doppler of 
LV and RV free wall long axis, and CT CACS using a MDCT scanner. Based on the CT findings 
patients were divided into: Group I with CACS<100 and Group II with CACS ≥100.  Although it 
is recommended to use a CAC score > 400, many international studies have shown that CAS of 
100 or more is an important change point, and it indicates that a plaque is present. 
All ETT and echocardiography measurements were analysed by two investigators blinded to 






Table 13 Provides information about the modifiable and non-modifiable cardiac risk factors of the 
study population. 
Table 13Modifiable and non-modifiable cardiac risk factors 
Risk factors Number of patients 
(%) 
Age>60 23 (65.7%) 
DM 5 (14.3%) 
Hypertension 23 (65.7%) 
Hypercholestolemia 19 (54%) 
Smoking 18 (51.4%) 
Family history 22 (62.9%) 
 
Echocardiographic examination  
All patients underwent rest and stress echocardiography. Two-dimensional echocardiography was 
used to acquire the apical 4 chamber view and M-mode and TDI measures were performed at the 
LV mitral annulus and RV free wall, at rest and during peak stress.  
Moreover, RWMA was assessed by four, two and three chamber views and rest and stress images 
were reviewed by two senior cardiologists.  
From the myocardial Doppler recordings, three velocities were made, the s’, an antegrade velocity 
during systole and two retrograde velocities, e’ during early diastole and a’ during late diastolic 





DSE results were reported as follows (Sicari and Cortigiani, 2017):  
• Normal, if there is normal wall motion at rest and increased myocardial thickening during 
stress.  
• Ischaemic, if normal at rest and wall motion abnormalities occur during stress.  
• Necrotic, wall motion abnormalities at rest, which remain during stress.  
• Viable, myocardial abnormalities at rest, which improve during stress. 
 More details of the procedure in chapter “2”. 
Coronary calcium scoring   
 
Computed tomography was used to assess coronary calcium. The CT was performed using a 64-
detector-row scanner (Somatom Sensation Cardiac 64; Siemens Medical Solutions, Forchheim, 
Germany).  
All lesions were added to calculate the total Agatston score (Becker et al., 2001), which was 
computed by summing the CACs of all foci in the epicardial coronary system.  
According to the CAC score, patients were classified into two groups; Group I with CAC <100 
and Group II with CAC >100.   
Coronary angiography  
The Judkin’s technique was used with at least four views of the left system and two views of the 




Statistical analysis was undertaken using a standard statistical software package (SPSS 18.0, SPSS 
Inc.). All continuous variables were expressed as mean ± SD.  A paired Student t-test was used to 
compare the difference between the two groups. A p-value less than 0.05 was considered 
statistically significant.  



































Figure 27 flow chart of the chest pain patients. 
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Persistent chest pain (n=20) 
Coronary calcium score (CAC) (n=35) 
CAC > 100 (n=15) CAC <100 (n=20) 
        Invasive coronary angiography (n=35) 





We aimed to illustrate the relationship between the presence of cardiac risk factors and its 
association with RWMA. We used the Chi-Square Distribution Calculator to obtain the p-values. 
When we compared the cardiac risk factors with the presence of RWMAs, >60 years old, male 
gender and hypertensive patients are linked to the presence of RWMAs during DSE, with 
significant p-values of 0.026, 0.002 and 0.003, respectively. The other risk factors such as age, 
DM, hypercholesterolemia, smoking and family history of CAD have no association with RWMAs 
during DSE, as shown in table 14 
 
Table 14 Cardiac risk factors with the presence of RWMAs during DSE. 





Mean CAC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             P-value 
Age>60 23 (65.7%) 13 (56.52%) 133 0.026 
Male 11 (31.4%) 9 (81.81%) 363 0.002 
DM 5 (14.3%) 3 (60%) 530 0.360 
Hypertension 23 (65.7%) 14 (60.86%) 289 0.003 
Hypercholestolaemia 19 (54%) 10 (52.63%) 290 0.176 
Smoking 18 (51.4%) 8 (44.44%) 214 0.558 






In terms of a positive or negative DSE and despite the number of segments which have wall motion 
abnormalities, we impact these results on CAC. When CAC of 400 and 100 are used as cut off 
values, the sensitivities of detecting peak RWMAs when the CAS is either ≥100 or ≥400 are very 
high, especially with CAC of 400, with a significant P-value of 0.001. In addition, the specificities 
are 100% and 90% for CAC of 400 and 100 respectively (Table 15 and 16). 
 
At rest, before starting the Dobutamine infusion, all the patients had normal wall motion. During 
stress, 15 patients developed a peak RWMA in different myocardial segments, and tables 17 and 
18 compare the presence of peak RWMAs against CAC with two different cut-off points. The 
results demonstrate a statistically significant association between the presence of CAC and stress 
induced ischaemia (p<0.001). 
 












CAC<400  Count (%) 20 (57.1) 7 (20) 27 (77.1)  
CAC≥400 Count (%) 0 (0.0) 8 (22.9) 8 (22.9)  





















CAC<100  Count (%) 18 (51.4) 2 (5.7) 20 (57.1)  
CAC≥100 Count (%) 2 (5.7) 13 (37.1) 15 (42.9)  
Total Count  20 (57.1) 15 (24.9) 35 (100) 0.001 
 
 
The LV long axis MAPSE significantly increased at the septal site (from 13.1±1.9 to 14.1±2.9 
mm, P=0.012), but failed to do so at the lateral site (from 14.8±2.5 to 15.2±3.4 mm, P=0.48). 
Systolic velocities (s’) significantly increased (from 7.2±1.7 to 11.9±2.9 cm/s, and from 7.9±2.4 
to 12.5±3.8 cm/s, P<0.0001 for both), at the septal and lateral sites, respectively. However, early 
diastolic velocities (e’) only increased in the lateral site (from 9.0±2.7 to 10.3±2.4 cm/s (P=0.008) 
and not in the septal site (from 7.7±1.8 to 8.1±2.4 cm/s, P=0.35). Atrial contraction (a’) increased 
in both lateral and septal sites with significant p-value as shown in table 18 and figures (28, 29 and 
30). CAC range was 0-1356 (mean 205.49). Paired student’s T-test was used for comparison 









Table 17: Compare the variables between rest and stress echocardiography. 
  Rest Stress P 









 M-Mode 14.8±2.5 15.2±3.4 0.48 

































On peak stress, systolic velocities of septal wall significantly increased in 20 patients out for 35, 
















There is no relationship between CAC score and any of the long axis measurements during rest 
and stress. However, TDI at different levels of the RV may have different results. Resting RV long 
axis amplitude, s’ was not different between the two groups. At peak stress, long axis amplitude 
did not significantly increase in Group I 22.3±3.2 to 24.2±3.5mm (P=0.12), and it even fell in 
Group II from 23.2±3.3 to 19.5±3.9 mm (P=0.05). RV s’ significantly increased from 10.9±1.9 to 
17.6±3.2 cm/s (P<0.0002) in Group I but to a lesser extent from 12.6±2.8 to 17.2±4.9 cm/s 
(P=0.013) in Group II. However, RV e’ failed to increase in group I 8.2±2.0 vs 10.1±3.3 cm/s 
(p=0.08), but increased in group II 7.1±1.5 vs 11.7±6.0 cm/s (P=0.04), as seen in table 18 and 
figure 31.       
Table 18: The comparison between Group I and -Group II for RV rest and stress. 
  Group 1 
CACS<100 
  Group 2 
CACS≥100 
  
  Rest Stress P Rest Stress P 
RV M-mode   22.3±3.2 24.2 ±3.5 0.12 23.2±3.3 19.5±3.9 0.05 
RV TDI S 10.9±1.9 17.6±3.2 <0.0001 12.6±2.8 17.2±4.9 0.013 
 E 8.2±2.0 10.1±3.3 0.08 7.1±1.5 11.7±6.0 0.04 




















In diastole, in the lateral segment, early diastolic velocities (e’) and late diastolic velocity (a’) 
significantly increased with stress (p=0.008 and p=0.001, respectively), whereas, only septal a’ 
(not septal e’) increased with stress. In group II (CAC ≥ 100) the systolic velocity increased with 
stress in lateral and septal segments. When we compared the lateral, septal, and RV separately, 
during rest and stress in group I, group II and both groups together, we find that in the lateral 
segment, apart from long axis M-mode, which is very slightly increased with stress (p-value 0.47), 
tissue Doppler s’, e’ and a’ increased significantly with stress.  
In group I patients, tissue Doppler velocity have the same changes in all the patients, whereas in 




Figure 32: Tissue Doppler and long axis m-mode of lateral segment during rest and stress for 











s' (p-value 0.00) e' (p-value 0.008) a' (p-value 0.00) M-mode (p-value
0.48)




Table 19 Tissue Doppler and long axis m-mode for lateral and septal segments during rest and 
stress in group I (n=20) 
  Rest Stress P 









 M-Mode 14.7±2.8 15.2±3.5 0.508 













Figure 33: Tissue Doppler and long axis m-mode of lateral segment during rest and stress for 













s' (p-value 0.00 e' (p-value 0.204) a' (p-value 0.00) M-mode (p-value
0.508)




Table 20 Tissue Doppler and long axis m-mode for lateral and septal segments during rest and 
stress in group II (n=15) 
  Rest Stress P 









 M-Mode 15.0±2.2 15.3±3.3 0.741 














Figure 34: Tissue Doppler and long axis m-mode of lateral segment during rest and stress for 













s' (p-value 0.00 e' (p-value 0.001) a' (p-value 0.077) M-mode (p-value
0.741)




In both groups, the tissue Doppler s’ and a’ of the septal segment increased significantly during 
stress, whereas, e’ did not significantly increase from 7.7±1.8 to 8.1±2.4, (p=0.35). Similarly, M-
mode long axis increased significantly on peak stress, and e’ increased slightly. Septal e’ did not 
change during stress in group II patients, and even decreased in group I. On the other hand, M-




Figure 35: Tissue Doppler and long axis m-mode of septal segment during rest and stress for 












s' (p-value 0.00) e' (p-value 0.35) a' (p-value 0.00) M-mode (p-value
0.012)





Figure 36: Tissue Doppler and long axis m-mode of septal segment during rest and stress for 




Figure 37: LV Tissue Doppler and long axis m-mode of septal segment during rest and stress for 










s' (p-value 0.00 e' (p-value 0.851) a' (p-value 0.00) M-mode (p-value
0.003)










s' (p-value 0.001 e' (p-value 0.148) a' (p-value 0.008) M-mode (p-value
0.671)




In the RV, s’ and a’ increased significantly in both patient groups with stress from 12.1±2.6 to 
18.2±4.1 and from 13.6±3.9 to 18.9±4.2, respectively (p-<0.0001 for both), whereas, e’ and 
TAPSE failed to significantly increase, as shown in table 21 and figure 38 
 
Table 21 The TDI and TAPSE of RV during rest and stress for both groups 
  Rest Stress P 























s' (p-value 0.00) e' (p-value 0.75 a' (p-value 0.00) M-mode (p-value
0.44)




In group I which has CAC is <100, the systolic velocity s’ and the late filling velocity a’ increased 
significantly with stress from 10.9±1.9 to 17.6±3.2 and from 13.4±3.4 to 18.8±3.9, respectively. 
In the same group, the early filling velocity in tissue Doppler (e’) and the TAPSE of the RV did 
not increase significantly. In group II, which has CAC ≥100, the tissue Doppler of the RV 
increased as in the first group, whereas the TAPSE decreased from 23.2±3.3 to 19.5±3.9. (Figures 

















s' (p-value 0.00) e' (p-value 0.08) a' (p-value 0.001) M-mode (p-value
0.12)






Figure 40:  (Tissue Doppler and long axis m-mode of RV during rest and stress for patients 
group II.) 
 
When the same patients were examined using invasive angiography, those patients who have mild 
atheroma or non-obstructive CAD (less than 50% stenosis) were compared with the presence of 
RWMAs by DSE results. The result show that DSE has a very high specificity of 95% and 
reasonably high sensitivity of 60% in identifying non-obstructed coronary stenosis, with a 











s' (p-value 0.013) e' (p-value 0.04) a' (p-value 0.003) M-mode (p-value
0.05)




















Count  1 9 10 
% of Total 2.9% 25.7% 28.6% 
Normal Count  19 6 25 
% of Total 54.3% 17.1% 71.4% 
Total Count  20 15 35 
% of Total 57.1% 42.9% 100% 
 
 
Discussion   
 
Fifty patients with typical chest pain presented to the cardiology department for cardiac 
investigations and all passed through different non-invasive cardiac investigations before 
undergoing invasive coronary angiography. Fifteen patients were excluded due to a negative or 
inconclusive ETT. Chest pain investigations started with the most practical and cheaper test until 
reaching the most expensive technique. All patients had a positive ETT with ST depression 
regardless of the presence of chest pain during the test. All patients were subsequently referred for 
a DSE to investigate the presence or absence of ischaemic heart disease via the assessment of stress 
induced RWMAs. This also provided the opportunity to measure TDI, TAPSE, and MAPSE 
during rest and stress. All positive and negative DSE patients who had persistent chest pain were 




In this study, DSE results impacted the results of CAC by MDCT and invasive coronary 
angiography results. Conventional coronary angiography is the gold standard test for identifying 
CAD, but if the diameter of coronary micro-vessels is less than 0.5 mm, it will be difficult for the 
cardiologist to visualise the small vessels (Berry et al., 2019).  
Our findings show that in patients with a positive ETT with ECG signs of ischaemia, but no 
significant luminal stenosis, coronary calcification determine the behaviour of the sub-endocardial 
function of the left and right ventricles by long axis studies. Unlike this study, nearly all the other 
studies compared the presence of RWMAs by DSE with the presence of coronary calcifications; 
however, this study added more valuable measurements during rest and stress to support the 
results. Patients with mild coronary calcification (score <100) had a greater increase in long axis 
amplitude and velocities than those with more than mild coronary calcium calcification (score 
>100). The significant increases were seen in all RV TDIs and M-mode. Moreover, significant 
increases were seen in LV TDIs and M-mode, including the lateral s’& a’ and septal M-mode, s’& 
a’. These findings suggest that the higher the calcium score the harder the wall and the more 
compromised the coronary flow reserve during stress, hence the development of markers of 
subendocardial ischaemia.  
Conventional investigation of coronary artery disease for angina is the demonstration of luminal 
stenosis by either conventional angiography or CT coronary angiography. Syndrome X patients, 
however, do not show any signs of significant stenosis (<50%) hence the clinical dilemma they 
present. We and others have (Nikolaou et al., 2004, Schuetz et al., 2010) previously demonstrated 
that symptomatic patients with significant calcification may show myocardial perfusion 
abnormalities as a sign of compromised blood supply, even in the absence of significant stenosis.  
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Some patients had mild coronary atheroma/calcification with non-significant stenosis, this can 
help in identifying early stages of CAD, and can be treated medically, and slow progression of 
advanced CAD by periodic follow-up.  
In those who do not have any atheroma by invasive angiography or any calcifications by MDCT 
but still have persistent chest pain, these are considered to have microvascular disease. In such 
patients, MDCT together with myocardial perfusion positron emission tomography (PET) imaging 
may help in the assessment of non-obstructive CAD which is related to the microvascular coronary 
flow obstruction. In women with cardiac chest pain and non-obstructed CAD, PET imaging can 
detect coronary microvascular dysfunction (Campisi and Marengo, 2017).  
Although we did not study myocardial perfusion in our cohort, the above findings mirror those but 
in a mechanical fashion in showing abnormal systolic and diastolic subendocardial function in 
syndrome X patients. These abnormalities were not limited to the left ventricle as is the case with 
myocardial perfusion but extended to the right ventricle too, as has previously been shown in 
patients with significant coronary disease. Thus, they demonstrate biventricular ischaemic 
subendocardial dysfunction. Although in this study we did not measure LVEF (contractile reserve) 
or global/segmental longitudinal, radial or circumferential strain or strain rate using speckle 
tracking like some other studies, we measured other important parameters, which demonstrate 
significant results, especially when added to the presence of RWMAs.  
Utsunomiya et al (2015) showed that RWMAs by DSE has high specificity but mild sensitivity for 
detecting CAD, Similarly, our study provides very high specificity and high sensitivity of 
identifying coronary atheroma or mild calcifications with less than 50% narrowing (non-
obstructive CAD).  
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The presence of RWMAs may be an early singe of progressive CAD, which can be treated 
medically or by angioplasty ± stenting and avoid bypass surgery. Utsunomiya el al (2015) also 
showed that both inducible RWMAs and coronary calcifications provided a very high sensitivity 
for ischemia in identifying CAD than the RWMAs alone. These results support our study, which 
showed that the combination of RWMAs and high CAC showed early calcified CAD or 
microvascular calcifications.  
There are few studies (Li et al., 2016, Geraiely et al., 2019), which compared the TDI of RV and 
LV systolic and/or diastolic functions with the presence of CAD but not CAC by MDCT. Most 
TDI studies assessed LV diastolic and not systolic function (Agarwal et al., 2012). We are the first 
team who compared both RWMAs and TDI measurements during rest and stress and which impact 
both CAC and invasive coronary angiography.  
Meta-analysis (Agarwal et al., 2012) showed that TDI systolic velocity can be used to identify 
CAD at rest, and the accuracy can be improved by adding RWMAs to the TDI. We are different, 
as all our patients had syndrome-X (non-obstructive CAD) with different levels of CAC by MDCT 
and different DSE results. At peak stress, systolic and diastolic function of the RV are impaired, 
mainly in patients with high CAC. TAPSE was impaired at peak stress whereas s’ was not. 
Although we consider this as impaired longitudinal function because of impaired TAPSE, the 
maintained s’ is contradictory and this may be due to measurement inaccuracies and the small 







In a group of patients with syndrome X and normal resting LV size and function, systolic and 
diastolic long axis ‘subendocardial’ function including amplitude and diastolic velocities, at peak 
stress were significantly abnormal.  
Since these disturbances are independent of the extent of CAC calcification, they may suggest 
evidence for microvascular disease, which is likely to compromise early diastolic coronary 
circulation. In the same group, patients with RWMAs have more chance of having coronary 
calcifications by MDCT than those with no inducible RWMA. Moreover, syndrome X patients 
exhibit clear evidence for TAPSE and diastolic right ventricular dysfunction at a fast heart rate, 
particularly with worsening coronary calcification. The small sample size may have influenced the 
















The overall aim of this thesis was to assess patients who were refereed to cardiology with stable 
cardiac chest pain. Conventional angiography is considered the gold standard for the diagnosis of 
significant and non-significant CAD. Although NICE guidelines currently recommend CT 
angiography as a first line investigation for patients presenting with stable chest pain, CT 
angiography was not commonly used when this thesis began and therefore CAC by MDCT was 
selected. As such, this thesis aimed to compare the diagnostic accuracy of MDCT with ETT, CMR 
and DSE. This thesis showed MDCT is more sensitive than ETT and CMR in predicting CAD, 
whereas ETT is more accurate in excluding CAD. Moreover, we find that there is association 
between MDCT and perfusion defect by CMR in patient with non-obstructive CAD. In addition, 
DSE is positive in patients with non-significant coronary stenosis but with high CAC and a positive 
ETT. We hypothesised that the presence of coronary calcifications could explain the patient’s 
symptoms through compromising blood flow to the myocardium (coronary circulation) 
particularly the distal circulation. There were three investigational pathways, which firstly 
included chest pain patients screened by ETT and MDCT, then by invasive coronary angiography; 
a second group of patients investigated using CMR before invasive angiography and thirdly, DSE 
was performed before invasive coronary angiography. The results of this thesis demonstrated that 
MDCT is more accurate than ETT in identifying significant CAD, whereas a negative ETT was 




Compared to CMR, MDCT was more accurate in detecting significant CAD. However, the burden 
of perfusion defects during stress was associated with a progressive increase in CAC in patients 
with non-obstructive CAD only. Finally, DSE was abnormal in patients with non-significant 
coronary stenosis but with high CAC and a positive ETT, which may suggest microvascular 
disease. In addition, resting wall motion abnormalities on echocardiography was associated with 
coronary calcification by MDCT.  
A CAC score of 46.5 was the best predictor of the presence of significant CA stenosis, with a 
sensitivity of 83% and specificity of 62%. This accuracy is irrespective of whether the severity of 
CA stenosis was taken as ≥50% or ≥70%. ETT proved to be a poorer predictor of CA stenosis, 
except for its high -ve predictive value. This finding is remarkable for two reasons. Firstly, it is a 
relatively low score; compared to what has been detected in asymptomatic populations, suggesting 
that even a small score but with symptoms should highlight the potential presence of significant 
stenosis. Secondly, our study shows that severe CA stenosis does not equate to severe CAC.  
For ETT, the predictive value increased with the presence of cardiac risk factors. Analysis of age 
showed that for CAC scores >0 and ≥400, age ≥70 gives a more accurate sensitivity but lower 
specificity, while the -ve predictive values are not different between age groups. For ETT, age ≥70 
gives a marginally higher sensitivity and specificity but lower –ve predictive value.  
Furthermore, analysis of gender showed that for a CAC score >0, there was little difference 
between results for males and females but for a CAC score ≥400, accuracy for males was higher 
for sensitivity but lower for specificity and –ve predictive value. Similarly, for ETT, accuracy in 
males was higher for both sensitivity and specificity, although lower for the –ve predictive value.  
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In ETT and CAC study, we compared two non-invasive methods of predicting significant CA 
stenosis in a group of symptomatic patients.  
CAC is an anatomical pathology which is considered a marker of subclinical atherosclerosis. 
Although it is well known that not all plaques become calcified, in most cases plaques are ‘mixed’ 
type (partly calcified and partly un-calcified). We managed to demonstrate a moderately close 
relationship between the presence of CAC and a coronary stenosis, although evidence exists 
showing that in some forms of atherosclerotic CAD this association does not exist, such as in acute 
coronary syndrome, where a significant percentage of patients have no evidence of CAC on the 
culprit lesion (Henneman et al., 2008, Schuijf et al., 2009). Possibly these lesions were calcified 
but by very small micro-particles of calcium, which cannot feasibly be measured by the 
conventional Agatston score.  
On the other hand, evidence also exists that patients with stable angina might present with severe 
calcification but no flow-limiting lesions (Blankstein et al., 2012), as was the case with some of 
our patients.  
Although not all studies found a close linear relationship between CAC area and degree of luminal 
stenosis (Mieres et al., 2007, Maffei et al., 2010a) as with ours, most studies show a very high 
sensitivity but a poor specificity of the CAC score for angiographic obstructive disease (Greenland 
et al., 2007, Budoff and Gul, 2008, Simons et al., 1992, Ardehali et al., 2007, Nieman et al., 2009b), 
possibly  associated with arterial remodelling. This has led several authors to conclude that CAC 
screening in stable symptomatic patients is a reliable means of excluding obstructive CAD 
(Nieman et al., 2009b).  
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Even in asymptomatic patients, Geluk et al (2007) found that CAC was significantly more reliable 
than ETT in predicting ≥50% CA stenosis. On the other hand, ETT is a functional test, the value 
of which is based on the demonstration of electrical evidence for myocardial ischaemia. It is the 
most commonly used investigation in open access chest pain clinics, as well as in post-myocardial 
infarction prognosis clinics (Sami et al., 1979).  
Our results show that the sensitivity and specificity of the ETT in predicting significant CA 
stenosis are significantly low compared to CAC. This, of course, does not refute the significant 
value of ETT in providing good prognostic value in patients with multi-vessel CAD (Bartel et al., 
1974), since it is based on the assessment of overall cardiac muscle function and its response to 
the severity of ischaemia rather than simply the presence of calcium deposition in the arterial wall. 
Therefore, it seems that the two investigations should be seen as complementary rather than in 
competition.  
Despite the fact that ETT has long been used in the workup of patients with suspected CAD 
(Greulich et al., 2012) and is predictive of cardiac events (Versteylen et al., 2013, Dedic et al., 
2011), a number of recent large studies have failed to show a strong predictive value in 
symptomatic intermediate-risk patients, with ETT having between a 30%-50% sensitivity to detect 
≥50% stenosis (Greulich et al., 2012, Blankstein et al., 2012, Maffei et al., 2010a, Maffei et al., 






Our result of 38.9% is entirely consistent with this. Only one study has shown a sensitivity of 71% 
for ≥50% stenosis (Hagnäs et al., 2017), while in another, sensitivity increased to 83% for detection 
of ≥70% stenosis (Blankstein et al., 2012); we found sensitivity to predict ≥70% narrowing 
remained at 39%. ETT specificity varies wildly, with study results ranging between 17% and 93% 
for detection of ≥50% stenosis (Hagnäs et al., 2017, Greulich et al., 2012, Blankstein et al., 2012, 
Maffei et al., 2010b, Lewis et al., 2005) we found a specificity of 53.7%.  
A meta-analysis showed that ETT was more useful at excluding CAD than predicting it but a 
positive test may be more predictive in younger patients (Banerjee et al., 2012). ETT is also known 
to be generally less accurate in women (Mieres et al., 2005).  
A meta-analysis showed that in women ETT had a sensitivity of 61% (vs 72% in men) and 
specificity of 70% (vs 77% in men), although the –ve predictive value is high for ETT (Gibbons 
et al., 2002). Our findings, however, showed that sensitivity was more accurate in women than 
men (54.8% vs 32.5%) for prediction of ≥50% stenosis and ≥70% stenosis (57.1% vs 32.1%), 
where predictive accuracy of ETT is compared against other imaging techniques, magnetic 
resonance imaging stress testing and stress echocardiography proved to be significantly more 
accurate (Banerjee et al., 2012, Greulich et al., 2012).  
In myocardium perfusion, when the myocardial perfusion impacted on coronary calcification, the 
result showed the relation between coronary calcification and the extent of myocardial perfusion 




CMR myocardial perfusion has been shown to have high accuracy in detecting CAD and related 
events (Nandalur et al., 2007, Gargiulo et al., 2013, Nagel et al., 1999, Falcão et al., 2013, Sicari 
et al., 2007, Hartlage et al., 2012, Takahashi et al., 2004, Schwitter et al., 2012, Keijer et al., 2000).  
 A subgroup of patients with either severe calcification but no HG stenosis or with impaired 
myocardial perfusion but no HG stenosis remains a clinical dilemma. There is currently no study 
that has shown an ideal way of describing these patients or proposed a strategy for managing them. 
The purpose of the CMR study was to assess the relationship between CAC and CMR myocardial 
perfusion in patients with HG coronary stenosis.  
The CMR study results concur with some of the findings in showing only a modest relationship 
between the presence of HG coronary stenosis and myocardial perfusion abnormalities by CMR.  
On the other hand, the CAC score was much more sensitive and specific in detecting HG stenosis, 
giving an area under the ROC curve of 80%.  
In addition, our findings highlight the relationship between CAC and stress myocardial perfusion 
defects, with an incremental increase in the number of myocardial segments showing perfusion 
defects, with stress, parallel to the progressive increase in CAC score, only in patients with no-HG 
stenosis.  
This suggests the potential development of myocardial ischaemia and symptoms is associated with 
arterial wall hardening rather than luminal narrowing by a stenosis, suggesting that the CAC score 
might be reflecting the extent of plaque burden, irrespective of luminal narrowing. We believe that 
we are the first to demonstrate that extensive CAC correlates with the diffuse pattern of myocardial 
perfusion defect in the absence of significant coronary stenosis, again suggesting an association 
between a perfusion defect and arterial hardening.  
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Pellika et al (2006) have shown a relationship between CAC and left ventricular RWMAs using 
stress echo but made no comment on the extent of obstructive lesions 
We too have recently shown parallel subendocardial abnormalities at peak stress in symptomatic 
patients with no coronary stenosis, particularly in those with significant calcification. This 
evidence suggests that CAC, particularly with high scores, is likely to be associated with 
compromise coronary blood flow reserve and hence myocardial perfusion at the time of increased 
demand (peak stress).  
Our findings in the DSE study show that in patients with angina-like symptoms but no significant 
luminal stenosis, coronary calcification is associated with the behaviour of the subendocardial 
function as shown by long axis studies of the left and right ventricles.  
Patients with mild coronary calcification (score <100) had a better increase in long axis amplitude 
and velocities than those with more than mild coronary calcium calcification (score >100).  
These findings suggest that a higher calcium score may be association with hardening of the 
arterial wall and a more compromised coronary flow reserve during stress, hence the development 
of markers of subendocardial ischaemia. Conventional investigation of CAD for angina is the 
demonstration of luminal stenosis by either conventional angiography or CT coronary 
angiography.  
Syndrome X patients, however, do not show any signs of significant stenosis (>50%) hence the 




We and others have (Gibson, 1991, Dedic et al., 2013) previously demonstrated that symptomatic 
patients with significant calcification may show myocardial perfusion abnormalities as a sign of 
compromised blood supply, even in the absence of significant stenosis.  
Although we did not study myocardial perfusion in our cohort, the DSE findings mirror those but 
in a mechanical fashion in showing abnormal systolic and diastolic subendocardial function in 
syndrome X patients.  These abnormalities were not limited to the left ventricle as is the case with 
myocardial perfusion but extended to the right ventricle too, as has previously been shown in 
patients with significant coronary disease.  
Mild coronary atheroma / calcification patients with non-obstructive CAD noticed in our study, 
this can help in identifying early stages of CAD, and can be treated medically, and delay 
progression of advanced CAD by periodic follow-up. In those who do not have any atheroma by 
invasive angiography or any calcifications by MDCT but still have persistent chest pain, this can 
be considered as microvascular disease.  
 
In such patients, MDCT together with myocardial perfusion positron emission tomography (PET) 
imaging may help in the assessment of non-obstructive CAD which is related to the microvascular 
coronary flow obstruction. In women with cardiac chest pain and non-obstructed CAD, PET 








Clinical implications  
In the ETT study, although our results clearly show that CAC screening is a better predictor of 
coronary stenosis than ETT, we would recommend using the two methods together, rather than 
either alone, since one is anatomical and the other is functional.  
Particularly in symptomatic patients with extensive CAC, ETT might be more informative in 
confirming myocardial ischaemia as an explanation of symptoms than a coronary angiogram 
which might not show any flow-limiting lesions and would give false reassurance. In myocardium 
perfusion, the coronary calcium score remains more accurate in detecting HG luminal stenosis 
over and above myocardial perfusion defects by CMR.  
Absolute reliance on luminal narrowing by either MDCT or conventional coronary angiography is 
likely to miss an important group of patients with limiting angina who do not demonstrate evidence 
for HG stenosis but suffer from wall hardening which compromises myocardial perfusion. This 
finding suggests an important role for the routine measurement of the CAC score in angina 




There was a gender difference between patients with HG stenosis and those without, but this does 
not seem to have influenced our results, since the relationship between CAC and CMR myocardial 
perfusion defects was shown in those with no-HG stenosis, negating the potential imbalance of 
males, who generally have higher incidence of CAC (Erbel et al., 2008).  
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Assessment of CMR perfusion was semi-quantitative but followed the international 
recommendations (Larghat et al., 2013). This study was retrospective in its design therefore subject 
to potential bias in patient selection. A significantly larger sample volume would have 
strengthened the relevance of our findings, particularly with the subgroup of patients with 
extensive calcification who showed clear evidence for myocardial perfusion abnormalities. 
Prospective study, however, would reduce potential selection and information bias. 
We relied on our data interpretation on the accuracy of the CAC measurements as previously 
reported by Achenbach et al (2001) who showed non-significant results in the variability of 
repeating CAC measuring by EBCT as well as the known low variability of the system we used 
(64-MDCT).  
Interobserver variability was performed in a retrospective way to all the echo measurements during 
rest and stress. Differences in intra and interobserver variability were assessed using SPSS. The 
interobserver variability is between 0.81 and 1.0, which means the measures are highly agreed.  
None of the patients we studied was clinically felt to need an FFR assessment and as such this 
information is not available.  
Finally, we did not assess CMR reproducibility, having considered the long experience of the 
radiologist reported and the lack of the potential competitor. With variability of CAC 








Coronary calcification and exercise stress testing provide different information with regards to the 
presence of CA stenosis. While calcification is more sensitive in predicting its presence, exercise 
testing is more accurate in excluding it. The two tests should be seen as complementary rather than 
competing. In term of myocardium perfusion, in a group of patients with exertional limiting 
angina, coronary calcification is more accurate in detecting high-grade luminal stenosis than 
myocardial perfusion defects. In addition, in patients with no stenosis, the incremental relationship 
between coronary calcium score and the extent of myocardial perfusion suggests association with 
coronary wall hardening as an additional mechanism for stress-induced angina other than luminal 
narrowing. These preliminary findings might have a clinical impact on the management strategies 
of these patients other than conventional therapy.  
In regard to DSE, syndrome X patients with normal resting LV size and function, systolic and 
diastolic long axis amplitude and diastolic velocities were significantly abnormal at peak stress. 
Since these disturbances are independent of the extent of CAC, this may suggest evidence of 
microcirculation disease, which is likely to compromise early diastolic coronary circulation. In the 
same group, patients with RWMAs have more chance of having coronary calcifications by MDCT 
than those with no inducible RWMA. Moreover, syndrome X patients exhibit clear evidence for 
reduced TAPSE and diastolic right ventricular dysfunction at a fast heart rate, particularly with 
worsening coronary calcification. The low sample size may have influenced the outcome of the 
study. 
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Table 23 ICC (intraclass correlation coefficient) for intra-observer reliability and inter-observer 
reliability. 
 
 Intra-observer ICC Inter-observer ICC 
REST   
   Lateral S 0.997 0.998 
   Lateral E 1 0.999 
   Lateral A 1 0.999 
   Septal S 0.997 0.996 
   Septal E 0.997 0.996 
   Septal A 0.998 0.997 
   RV S 1 0.998 
   RV E 1 0.997 
   RV A 1 0.999 
   M-lateral (MAPSE) 0.908 0.889 
   M-septal 0.833 0.851 
   M-RV (TAPSE) 0.992 0.988 
   
STRESS   
   Lateral S 1 0.999 
   Lateral E 0.999 0.999 
   Lateral A 0.999 1 
   Septal S 1 0.997 
   Septal E 0.998 0.998 
   Septal A 0.999 0.998 
   RV S 1 0.999 
   RV E 0.999 1 
   RV A 1 0.999 
   M-lateral (MAPSE) 0.989 0.973 
   M-septal 0.956 0.964 






















Coronary calcium score is superior to exercise tolerance testing in predicting significant coronary artery 
stenosis  
Tarek Bengrid, Rachel Nicoll, Ying Zhao, Axel Schmermund and Michael Y Henein  
ABSTRACT Aim: To determine whether coronary calcification is more predictive of significant coronary 
artery stenosis than exercise tolerance testing in symptomatic patients.  
Methods: We retrospectively studied 360 patients, mean age 64.7±9.8y, 59% males, who presented to 
Bethanien Hospital, Frankfurt, Germany with angina-like symptoms and who underwent conventional 
angiography, CT scanning for coronary artery calcification (CAC) and exercise tolerance testing (ETT).    
Results: A CAC score >0 was superior to ETT for prediction of significant coronary artery stenosis (≥50% 
narrowing), with sensitivity 97% vs. 39% (p<0.001) but specificity was only 26% vs. 54% (p<0.001). Patients 
aged ≥70 had higher sensitivity for CAC ≥400 in predicting CA stenosis compared to those aged <70 (62% 
vs. 26%, p=0.018) and in predicting single vessel disease (SVD) (74% vs. 28%, p=0.008) and multivessel 
disease (MVD) (65% vs. 28%, p=0.039). The respective specificities for CAC >0 were significantly lower in 
those aged ≥70 compared to age <70 for SVD (5% vs. 26%, p=0.052) and MVD (9% vs. 60%, p=0.018). ROC 
curve analysis showed a CAC score of 46.5 as having the highest sensitivity and specificity (83% and 62%, 
respectively, p<0.001) for predicting ≥50% CA stenosis with an area under the curve of 76%.  
Conclusion: In symptomatic patients, coronary artery calcium score is more accurate in predicting the 
presence of significant coronary stenosis but exercise tolerance testing is more specific in excluding 





CORONARY CALCIFICATION COMPROMISES MYOCARDIAL PERFUSION IRRESPECTIVE OF LUMINAL 
STENOSIS  
Michael Y. Henein, Tarek Bengrid, Rachel Nicoll, Ying Zhao, Bengt Johansson and Axel Schmermund   
ABSTRACT  
Aim: The aim of this study was to evaluate the relationship between coronary artery calcification (CAC) 
assessed by multi-detector computed tomography (MDCT) and myocardial perfusion assessed by cardiac 
magnetic resonance imaging (CMR) in a group of symptomatic patients.  
Method: Retrospective analysis of 120 patients (age 65.1±8.9 years, 88 males) who presented with 
atypical chest pain to Bethanien Hospital, Frankfurt, Germany, between 2007 and 2010 and who 
underwent CAC scoring using MDCT, CMR and conventional coronary angiography. Patients were divided 
into those with high grade (HG) stenosis (n=67, age 65.1±9.4 years) and those with no HG stenosis (n=53, 
age 65.1±8.6 years).   
Results: There were more males with HG stenosis (82.1% vs. 62.3%, p=0.015), in whom the percentage 
and number of abnormal perfusion segments were higher at rest (37.3% vs. 17%, p=0.014) but not 
different with stress (p=0.83) from those with no-HG stenosis. Thirty four patients had myocardial 
perfusion abnormalities at rest and twenty six patients developed perfusion defects with stress. Stress-
induced myocardial perfusion defects were 22.4% sensitive and 79.2% specific for detecting HG stenosis. 
The CAC score was lower in patients with no-HG stenosis compared to those with HG stenosis (p<0.0001). 
On the ROC curve, a CAC score of 293 had a sensitivity of 71.6% and specificity of 83% in predicting HG 
stenosis [(AUC 0.80 (p<0.0001)]. A CAC score of 293 or the presence of at least 1 segment myocardial 
perfusion abnormality was 74.6% sensitive and 71.7% specific in detecting HG stenosis, the respective 
values for the two abnormalities combined being 19.4% and 90.6%. The severity of CAC correlated with 
the extent of myocardial perfusion in the patient group as a whole with stress (r=0.22, p=0.015), 
particularly in those with no-HG stenosis (r=0.31, p=0.022). A CAC score of 293 was 31.6% sensitive and 
87.3% specific in detecting myocardial perfusion abnormalities.   
 Conclusion: In a group of patients with exertional angina, coronary calcification is more accurate in 
detecting high grade luminal stenosis than myocardial perfusion defects. In addition, in patients with no 
stenosis the incremental relationship between coronary calcium score and the extent of myocardial 
perfusion suggests coronary wall hardening as an additional mechanism for stress-induced angina other 
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than luminal narrowing. These preliminary findings might have a clinical impact on management 
strategies of these patients other than conventional therapy.  
 
Effect of coronary calcium score on subendocardial function in patients with   Syndrome X: A tissue 
Doppler dobutamine stress echocardiography study 
Tarek Bengrid, Ying Zhao, and Michael Y Henein 
Background and Aim: Patients with Syndrome X remain a clinical challenge in their 
management. We aimed in this study to determine the relationship between coronary calcification, 
measured by Agatstaon score and stress changes in subendocardial function as shown by left 
ventricular (LV) long axis amplitude and systolic and diastolic velocities.  
Method: We examined 35 patients with Syndrome X (24 female, mean age 62 years), all complained of 
angina like symptoms, had > 1mm ST shift on exercise but no obstructive coronary disease on conventional 
angiography. No patient had prior coronary event, valve disease or LVEF <55%. All patients underwent 
dobutamine stress echocardiography (DSE) including M-mode and tissue Doppler and CT coronary calcium 
scoring CAC) using a multidetector CT system  
Results: LV long axis amplitude increased at septal site (from 13.1±1.9 to 14.1±2.9 mm, P=0.012), but 
failed to do so at the lateral site (from 14.8±2.5 to 15.2±3.4 mm, P=0.48). Systolic velocities (s’) increased 
(from 7.2±1.7 to 11.9±2.9 cm/s, and from 7.9±2.4 to 12.5±3.8 cm/s, P<0.0001 for both), at the two sites, 
respectively. However, early diastolic velocities (e’) only increased in lateral site (from 9.0±2.7 to 10.3±2.4 
cm/s (P=0.008) but not in septal site (from 7.7±1.8 to 8.1±2.4 cm/s, P=0.35). CAC range was 0-1356 (mean 
205.49). There was no relationship between CAC score and any of the long axis measurements.   
Conclusion: In a group of patients with syndrome X and normal resting LV size and function systolic and 
diastolic long axis ‘subendocardial’ function including amplitude and diastolic velocities, at fast heart rate 
were significantly abnormal. Since these disturbances are independent of the extent of CAC calcification, 
they may suggest an evidence for microcirculation disease, which is likely to compromise early diastolic 





Disturbed right ventricular function response to dobutamine stress in Syndrome X patients: A 
potential effect of coronary calcification. 
 
Tarek Bengrid, Ying Zhao, Michael Y Henein 
 
Background and Aims: The exact mechanism behind symptoms in Syndrome X patients remains 
disputable. We aimed in this study to assess in detail right ventricular (RV) function response to heart rate 
increase with dobutamine and compare it with the extent of coronary artery calcification score (CACS).  
 
Methods: Thirty five patients with Syndrome X (24 female, mean age 62 years), who complained of angina 
like symptoms, had > 1mm ST shift on exercise but no obstructive coronary disease on conventional 
angiography were recruited. All patients had normal LV ejection fraction (>55%) and RV size, inlet 
diameter (<3.6 cm) who underwent dobutamine stress echocardiography (DSE) including M-mode and 
tissue Doppler of RV free wall and CACS  using a multidetector CT system. Based on CT findings patients 
were divided into: Group I with CACS<100 and Group II with CACS >100. 
 
Results: Resting RV long axis amplitude, s’ was not different between the two groups. At peak stress, long 
axis amplitude did not increase (as it does in normal) in Group I 22.3±3.2 to 24.2±3.5mm (P=0.12), and it 
even fell in Group II from 23.2±3.3 to 19.5±3.9 mm (P=0.05). RV s’ increased from 10.9±1.9 to 17.6±3.2 
cm/s (P<0.0002) in Group I but to a lesser extent from 12.6±2.8 to 17.2±4.9 cm/s (P=0.013) in Group II. 
However RV e’ failed to increase in the group I 8.2±2.0 vs 10.1±3.3 cm/s (p=0.08), but increased in group 
2 7.1±1.5 vs 11.7±6.0 cm/s (P=0.04).   
 
Conclusion: Syndrome X patients exhibit clear evidence for systolic and diastolic right ventricular 
dysfunction at fast heart rate, particularly with worsening coronary calcification.     
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